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Neural interface technologies that link the nervous system and the outside world by either 
stimulating or recording from neural tissue, show great promise for patients suffering from 
various neurological injuries or disorders. However, the poor recording stability and longevity of 
neural interface devices (neural probes) is an imminent obstacle to their advance in widespread 
clinical applications. The dominant factor that affects chronic neural recordings has been 
reported to be the inflammatory tissue response including neuronal loss and gliosis at the 
electrode/tissue interface.  
In this study, we proposed to modify the surface of neural probes with the neural 
adhesion molecule L1. The L1 molecule is known to specifically promote neurite outgrowth and 
neuronal survival. We hypothesized that surface immobilization of L1, may introduce a neuron 
friendly environment to maintain healthy neuronal density and promote neurite outgrowth 
around the recording electrodes. Consequently, this phenomenon could reduce gliosis formation. 
Silane chemistry and the heterobifunctional coupling agent, 4-Maleimidobutyric acid N-
hydroxysuccinimide ester (GMBS), were used to covalently bind L1 onto the silicon surface. 
Polyethylene glycol (PEG)-NH2 was co-immobilized to cap unreacted GMBS groups and 
prevent non-specific cell attachment. Primary murine neurons and astrocytes were cultured on 
L1 modified and control surfaces. The L1 surfaces showed promoted neuronal attachment and 
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neurite outgrowth but significantly reduced astrocyte attachment relative to controls. L1 vs. non 
modified control probes were implanted in the rat motor cortex for 1, 4, and 8 weeks. Extensive 
immunohistochemistry and quantitative image analysis were performed to assess the brain tissue 
response to implants. The results showed that the L1 modified probes had no loss of neurons 
around the implant interface and showed a significant increase of axonal density compared to the 
control at all time points. Additionally, significantly reduced glia cell activation and recruitment 
was observed at the vicinity of the L1 modified probes. As a final step, we have developed a 
method to evaluate the chronic recording performance of neural probes in the rat somatosensory 
cortex from whisker stimulation and cortical recordings.  
Based on our results we conclude that the L1 biomolecule shows neuroprotective and 
neurogenerative properties while inhibiting gliosis. The L1 surface coating can be a promising 
strategy to improve the biocompatibility of all types of neural probes and their chronic 
performance in the brain.  
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1.0      INTRODUCTION 
 
The idea of using neural signals to control external prosthetics first surfaced 3 decades ago. Since 
then an abundance of research has been devoted to understanding the neuronal circuitry of the 
relevant brain structures, developing computer hardware and software algorithms to translate 
neuronal potentials into prosthetic control, and engineering biocompatible recording electrode 
arrays. However, the clinical translation of these arrays has been greatly impeded due to several 
fundamental and unresolved research questions. Neural signal degradation during chronic 
implantation of these electrodes in the brain tissue remains the main challenge, raising questions 
such as: Is the signal degradation the result of insertion trauma, micromotion, mechanical 
mismatch, or consequences of a gliosis formation that arises simply from a chronic foreign body 
response? Other questions involve the fate of neurons adjacent to the recording electrodes. Are 
these neurons killed during insertion injury, do they die through the inhibitory cues expressed by 
the cells that mediate gliosis, or are they shifted by gliosis activated cells? What are the best 
methods to minimize or treat implant injury, and what roles do electrode size, shape, surface 
chemistry, mechanical impedance, and insulating material play? Research is being conducted 
worldwide to answer these questions and others that arise during the way. Only when these 
questions are answered can this technology successfully be applied to widespread use in humans.  
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1.1 MOTIVATION: THE NEED FOR CORTICAL NEURAL INTERFACE SYSTEMS 
Research to develop technology that links the nervous system and the outside world by either 
stimulating or recording from neural tissue has been examined for decades. This area of research, 
which is referred to as; brain-machine interfaces, brain-computer interfaces, neural prostheses, or 
neural interface systems, offers to assist people suffering from sensory, motor, or other 
neurological disabilities [1-3]. In addition, the emerging technology could provide fundamental 
scientific knowledge about the human nervous system and its function.  
 
Figure 1. Different emerging neural interface technologies. (NeuroProbes) 
 
To date the most successful neural interfaces available to humans in widespread clinical 
applications are the electrical stimulation devices. These devices include the cochlear implants, 
which help to restore audition in the hearing impaired [4], and the deep brain stimulator (DBS), 
which relieve symptoms of Parkinson’s disease and dystonia when available drug therapies fail 
[5] (Figure 1).  
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Neural interfaces that record electrical potentials from the brain can predict cognitive 
intentions in the form of motor outputs such as movement of a computer cursor, a robot, or an 
artificial limb [2]. These systems are at an early stage in clinical trials [6-11] and are designed as 
assistive technologies to help patients suffering from spinal cord injury trauma, strokes that 
interrupt descending motor pathways, degenerative disorders such as amyotrophic lateral 
sclerosis (ALS), cerebral palsy, muscular dystrophy and/or limb amputation [3, 8-15]. The 
clinical need for these prostheses increases as the world population’s average age increases. 
These prostheses also have the potential use in interfacing with rising environmental and 
technological changes in society.   
Developed over 40 years ago, the first neural recording electrodes were reported to be 
mircrowires [16]. These microwires were composed of fine stainless steel or tungsten wires 
(diameter of 20-50 µm) and insulated with Teflon or polyimide. Since then, significant research 
has been done in manufacturing and perfecting the technology and composition of these 
electrodes. To date, the most well-known recording electrodes in the neural research and clinical 
fields are the planar silicon substrate based microprobe devices developed at the University of 
Michigan, now owned by NeuroNexus Technologies [17], and the microwire array developed at 
the University of Utah, now owned by BrainGate [18] (Figure 2). The NeuroNexus silicon 
probes are fabricated using methods applied in the semiconductor industry.  Boron etch-stop 
micromachining is used as an initial processing step of the silicon wafer to precisely delineate 
the shape of the probe which can have defined features within ±1 µm. Several steps are used to 
deposit silicon dioxide and silicon nitride for insulation, followed by photolithography to pattern 
the interconnects and the recording sites (typically iridium). Standard shank thickness is 15 µm 
but the boron doping process offers the ability to manufacture a wide variety of 2D, and most 
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recently 3D designs that can vary in the number of electrode sites and shank configurations 
(Figure 2A). During chronic implantations, these probes are implanted manually in the brain 
using forceps through the incised dura layer. The probe’s percutaneous connectors are secured to 
the skull and in contrast to the mircrowires, a flexible ribbon cable allows for these probes to  
 
 
Figure 2. The two prevalent cortical devices. (A) The planar approach device also known as the Michigan 
probe (NeuroNexus Technologies). (B) The microwire device also known as the Utah array (BrainGate). 
 
float with the brain as it pulses. The BrainGate arrays are micro-machined using a solid block of 
silicon and an acid-etching technique that results in a 3D array typically composed of 10 x 10 
arrangement of needles protruding from a 4 x 4 mm surface (Figure 2B). These silicon needles (1 
– 1.5 mm in length) are converted into electrodes by the application of a four part multi-layer 
metal deposition of Pt, Ti, W then Pt of total thickness 10,000 Angstroms onto the first 50 – 100 
μm of each tip to allow for recording. These arrays can be implanted into the cortex through the 
dura layer using a high-speed controller tool. These arrays are machined to adjust to cortical 
movement during chronic implantation. To date, BrainGate neural implants have been FDA 
approved for clinical trials, while the NeuroNexus probes remain as research prototypes. The 
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clinical trials in the arena of motor prosthetics using BrainGate implants are conducted by 
Donohue et al. [7, 8, 10]. Human implantation during these cases has been strictly 
investigational. Thus far, several tetraplegic patients have undergone trial implantations and have 
successfully controlled a robotic arm, computer cursor, and even a wheelchair through their brain 
signals [7, 8, 10].  
Several other prototypes of microelectrode arrays exist for research applications and are 
made of significantly different material compositions, geometries, manufacturing processes, 
degrees of invasiveness, and degrees of biocompatibility [12, 19-22]. However, the majority of 
all of the above mentioned neural probes are reported to fail within weeks to months after 
implantation [23-27]. Research investigators aim to characterize and optimize individual aspects 
of probe designs that are believed to contribute to their failure, such as substrate composition, 
geometry, surface features, and insertion techniques [28-30]. While others seek to develop 
electrodes with alternative surface configurations and applied polymer or drug-eluting coatings 
[31-33]. However, although the engineering aspect of the neural interface technology has been 
advancing, to date, no microelectrode configuration has successfully evaded the foreign body 
response. This obstacle is one of the major impeding factors to the advancement of cortical 
neural interfaces in widespread clinical applications.   
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1.2 IMPLANT TISSUE RESPONSE AT THE ELECTRODE-TISSUE INTERFACE 
When an artificial material is inserted in the host body creating a wound, the body is 
programmed to respond with a series of molecular and cellular events to repair the resulting 
damage. Host reactions following implantation of biomaterials in the body include initial tissue 
injury, blood material interactions, provisional matrix formation, acute inflammation, chronic 
inflammation, granulation tissue development, foreign body reaction, and fibrosis/fibrous 
capsule development [34]. The observed inflammatory response in the brain follows similar 
events. However, due to the novelty of brain implant systems, our understanding of cortical 
inflammatory response and the function of the molecule/cell interactions involved is at an early 
stage. Several assumptions and hypotheses made by researchers who are studying the effects of 
biomaterial implants in the brain tissue are discussed below.  
1.2.1 Cells involved and the brain inflammatory response 
Astrocytes are highly differentiated cells that are distributed in the central nervous system (CNS) 
in a contiguous fashion and make numerous essential contributions to normal function in the 
healthy CNS, including regulation of blood flow, providing energy metabolites to neurons, 
participation in synaptic function and plasticity, and maintenance of the extracellular balance of 
ions, fluid balance and transmitters [29]. In addition, astrocytes are known to respond to all 
forms of CNS insults such as infection, trauma, ischemia, and neurodegenerative disease. This 
process is commonly referred to as reactive astrogliosis. Epidermal growth factor (EGF), 
fibroblast growth factor (FGF), endothelin 1, and adenosine triphosphate (ATP) are some of the 
7 
 
several molecular triggers that lead to proliferation of reactive astrocytes in vivo [35]. Our 
understanding about the functions and effects of reactive astrogliosis and its impact on neural 
function is at an early stage. 
In addition to astrocytes, microglia represent the second major population of glial 
protective cells within the CNS. Microglia are derived from the monocyte lineage and are 
ubiquitously distributed throughout the brain and spinal cord. One of their main functions is to 
monitor and sustain neuronal health. These cells are known to be very sensitive to any minor 
disturbances in CNS homeostasis, and they readily become activated (changing in both 
phenotype and function) during most neuropathologic conditions, including peripheral nerve 
injury, trauma and stroke, inflammatory disease, and neurotoxicant-induced neuronal injury [36]. 
Another function taken on by microglia when activated is to cluster around a foreign body and 
degrade it enzymatically. When a foreign body cannot be degraded, the phenomenon is called 
“frustrated phagocytosis”. During frustrated phagocytosis pro-necrotic substances are released 
into the immediate vicinity of the foreign body, which eventually contribute to cell death [36]. 
Hypotheses are made that this phenomenon might also occur during probe implantation in the 
brain.  
1.2.2 Acute and chronic gliosis formation 
The response to neural implants in the CNS is a complex response involving interactions 
between at least 4 cell types: microglia/macrophages (brain and blood-borne), astrocytes, 
meningeal fibroblasts, and neurons (Figure 3). Mechanical trauma caused by a stab wound 
insertion of a neural implant can sever blood vessels, neuronal cell processes, glia cells, 
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extracellular matrix, and collagen fibrils. Blood vessel rupture releases erythrocytes, clotting 
factors, and other inflammatory factors which aid in macrophage recruitment and eventual 
cell/tissue rebuilding [37]. Following this implant injury a series of other molecular cascades are 
followed by activation and recruitment of glia cells. More specifically tissue response to neural 
implants has been categorized into two stages: the acute inflammatory response and the chronic 
inflammatory response (Figure 3). The acute response (Figure 3A) is triggered by device 
insertion and begins to subside after a week. During the acute response, the activated microglia 
are recruited immediately around the implant site and can be visualized by immunohistochemical 
staining as early as 1 day post-implantation [38]. Pro-inflammatory cytokines released by 
activated microglia recruit and activate astrocytes, which respond with increased expression of 
glial fibrillary protein (GFAP) and a change in morphology [39].  It has been shown that this 
acute response is temporary, as removal of an implant immediately after insertion leaves little 
evidence of a cellular reaction in the tissue a month after recovery [40-42]. On the other hand, 
the chronic response (Figure 3B) to cortical implants, remains for as long a period as has been 
studied (up to six months) in rats and non-human primates [38, 43-48]. The chronic 
inflammation response is characterized by the presence of activated microglia, macrophages, and 
reactive astrocytes, which are a part of gliosis encapsulation of the implanted electrodes. The 
progression of events of gliosis formation around implanted cortical recording electrodes has 
been documented in several studies [29, 30, 37, 38, 49-59]. Although tissue reaction varies from 
species to species and type/size of implant, it has been shown at 1 to 2 weeks, GFAP staining 
reveals a reactive astrocyte region around the implants with a radius of 500 µm. This reactive 
region shrinks over time, and the layer of cells immediately adjacent to the implant becomes 
more dense and organized. At 2 and 4 weeks, activated astrocytes around the implant have 
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extended their processes toward the implant. At 6 weeks, the mesh of astrocytic processes has 
become so strong and dense that in some cases the removal of the implant did not result in the 
collapse of cellular processes into the implant void [58]. It is important to note that in most of the 
histological studies the electrodes were not connected to an external electrical connector attached 
to the skull, also called tethering of the probe. Such untethered electrodes may underestimate the 
actual reactivity caused by electrically active implants that may transmit forces caused by the 
connection to the implanted electrode. 
 
 
Figure 3. Schematic of the acute and chronic tissue responses following neural probe implantation.  The 
acute response (A) is characterized by vasculature damage, neuronal injury, plasma protein adsorptions, recruitment 
of activated microglia, and a broad region of reactive astrocyte around the implant. The chronic response (B) is 
characterized by a condensed sheath of cells primarily composed of activated microglia and reactive astrocytes 
around the insertion site.  Degeneration of neuronal processes and addition neuronal loss may also be seen [60]. 
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1.2.3 Neuronal response at the implant/tissue interface 
The density of neurons and axonal proximal to the electrode has been reported to vary from 
implant to implant, and even between electrodes implanted at different sites in the same animal 
[30, 37, 54-56, 58]. This can be due to the shape of the implant, implant placement in the brain 
tissue, electrode position, species differences, and gliosis formation and its implications to 
neuronal fate.  
 Several studies have reported the decrease of neuronal density around implants and have 
called this phenomenon a “kill zone” [30, 37, 54, 55]. The “kill zone” is defined as the region of 
significantly lower or nonexistent neuronal density found within approximately 50 to more than 
100 µm away from the electrode. Even very small increases in the separation between the 
electrode and local neuronal and axon population can insulate the electrode completely, as 
electrodes must be within a 100 µm distance to get a significant signal. While gliosis formation 
effectively seals off the implant, it is also known to block neurite growth and axonal regeneration 
both chemically and physically [51, 61]. It has been shown that one class of molecules, 
chondroitin sulfate proteoglycans (CSPGs), are up-regulated by reactive astrocytes and are one 
of the main inhibitory molecules in glial scar and encapsulation [35].  
Several other possible causes have been suggested to describe the neuronal response, 
such as neuronal death due to insertion trauma or chronic inflammation [37], inevitable 
migration and micromotion of the implant that increase the distance between the electrode and 
adjacent neurons [55], implant material not being attractive to neuronal attachment and growth 
[60], development of chronic gliosis [29, 58, 62, 63] which may suppress neuronal activity or 
form a sheath that isolates neurons from recording electrodes, and finally localized 
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neurodegeneration caused by the inflammatory persistence of the cellular encapsulation around 
these implants [51].  
1.2.4 Hypothesis and approach 
The following hypothetical assumptions are made when it comes to the failure mechanisms and 
degradation of neural signals: 1) Gliosis encapsulation insulates the electrode surface by 
reducing electrochemical impedance and impedes diffusion and perhaps current flow which in 
turn decrease signal to noise ratio of the recorded data, 2) Gliosis formation around the implant 
increases the distance of electrode surface from recording neurons by pushing away neuronal 
bodies, and 3) Neuronal cell death or axonal damage secondary to implantation trauma and 
associated with the inflammatory response reduces or eliminates electrophysiological activity. 
We believe that these problems could be solved by presenting the brain with a “biologically 
inspired electrode”. This could lead to solving the long-term goal of enhancing and sustaining 
neuronal connectivity with the electrode sites.  
1.3 MODIFICATIONS OF NEURAL IMPLANTS 
 Researchers are continuously altering the material compositions and geometries of cortical 
arrays with hopes of discovering a combination that will allow for chronic and stable recordings. 
Despite numerous efforts, it might be 5-10 years until a microelectrode array design suspends the 
host immune response effectively and remains fully functional. The basics of the addressed 
problem are to ideally regulate the tissue/interface environment so that neurites are attracted to 
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the vicinity of the recording surface before encapsulation takes place. Gliosis suppression is 
another goal.  
A number of ongoing surface modification studies are attempting to address the 
probe/tissue interface issue using different approaches.  Several techniques have been attempted 
in order to mitigate the response of cortical tissue to implanted microelectrodes. Some studies 
focus on modifying probe insertion techniques, which have been shown to effect on initial 
implant injury response. Rennaker et al. suggest that improvement of insertion techniques, such 
as slow versus fast insertion, have an effect on signal to noise ratio of recordings [64]. While 
Kralik et al. shows improved recordings using drivable microelectrode arrays. Kralik at al. 
attempted to avoid the encapsulation and loss of neural signals by slowly inserting the electrode 
deeper into the brain tissue at different time points [65]. Several other studies are working on 
modifying material properties and design of the probes. These studies report that more compliant 
materials will reduce inflammation [28, 42], and that providing a probe with holes along the 
shaft will reduce gliosis and allow for neurite stability [28]. Moxon et al. reports etching the 
surface of electrodes by creating nano-scale surface features, increases neuronal cell adhesion, 
and thus increases longevity of recordings [33]. 
The surface properties of neural implants have been studied and modified using 
micro/nano surface science. The general hypothesis of these studies is that increasing electrode 
surface area properties will enhance recording stability. Conductive polymers have been applied 
to silicon-substrate microelectrodes probes to decrease site impedance [32, 66, 67]. Laminin 
coatings have been also applied on the surface to reduce gliosis [68]. More recently, nanotubes 
formed from conductive polymers have been applied to electrode sites, both reducing site 
impedance and providing a platform for controlled drug release [69, 70]. Systemic and local 
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release of anti-inflammatory molecules and drugs is a sought after approach by several 
researchers. Anti-inflammatory drugs such as dexamethasone have been used locally and 
systemically used to try to reduce activation of astrocytes and microglia at the implantation site 
[71-75]. Dexamethasone is a drug in the class of steroid hormones that serves as anti-
inflammatory and anti-immunosuppressant. In addition, Purcell et al. show that systemic release 
of the drug Flavopiridol reduces the impedance due to gliosis but has no effect on recording 
stability [31]. Flavopiridol is an experimental drug used for inducing apoptosis in cancerous 
cells. 
Several investigators have also proposed neural stem cells approaches to improve the 
biocompatibility of these electrode arrays [76-78]. Our group has shown that neural progenitor 
cells (NPCs) can differentiate and strongly adhere to laminin-immobilized surfaces, providing a 
stable matrix for these cells to be implanted in brain tissue on the neural probe's surface. In 
addition, NPCs were found to improve the astrocytic reaction around the implant site [78].  
Although many of these methods are promising and have the same goal, none have 
emerged as a definitive solution to the problem of reactive tissue response. The importance of 
improving tissue inflammation is determinant to the recoding stability of these implants for 
chronic applications. The main challenge remains in the lack of the ultimate solution due to the 
manufacturing techniques and the material composition of these probes. In this thesis, we 
describe one solution that could provide a better integration of the probe with the brain tissue and 
thus better chronic recording stability.  
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2.0  SURFACE IMMOBILIZATION OF NEURAL ADHESION MOLECULE L1 FOR 
IMPROVING THE BIOCOMPATIBILITY OF CHRONIC NEURAL PROBES: IN 
VITRO CHARACTERIZAITON 
2.1 ABSTRACT 
Silicon-based implantable neural electrode arrays are known to experience failure during long-
term recording, partially due to undesirable host tissue responses. Surface modification and 
immobilization of biomolecules may provide a means to improve their biocompatibility and 
integration within the host brain tissue. Here we report the immobilization of L1 and laminin 
biomolecules on the silicon surface and compare their effects on neuronal and astrocyte cultures 
in vitro. Laminin, an extracellular matrix (ECM) protein that interacts with a variety of cell 
types, is known to be an excellent substrate for neuronal attachment and growth. L1 is a neuronal 
adhesion molecule that specifically promotes neurite outgrowth and neuronal survival. Silane 
chemistry and the heterobifunctional coupling agent, 4-Maleimidobutyric acid N-
hydroxysuccinimide ester (GMBS), were used to covalently bind these biomolecules onto the 
silicon surface. Surface immobilization of biomolecules was verified by goniometry, dual 
polarization interferometry (DPI), and immunostaining techniques. Silicon dioxide coated wafers 
were used to mimic the surface of silicon-based implantable neural probes. After covalently 
binding the biomolecules, polyethylene glycol (PEG)-NH2 was used to cap the unreacted GMBS 
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groups. Primary murine neurons and astrocytes were used to evaluate the interaction of the 
modified surfaces. Both L1 and laminin modified surfaces promoted neuronal attachment, while 
the L1 surface demonstrated significantly higher levels of neurite outgrowth (p<0.05). In 
addition, the laminin surface promoted astrocyte attachment, while the L1 surface showed 
significantly reduced levels of astrocyte attachment relative to controls (p<0.05). These results 
demonstrate the unique properties of L1 as a potent promoter of neurite outgrowth and a possible 
inhibitor of astrocytes. This further illustrates L1’s vast potential to improve the biocompatibility 
and chronic recording performance of neural probes.  
2.2 INTRODUCTION 
Silicon-based neural probes that permit recording and stimulation of specific sites in the brain 
experience failure during long-term recording, partly due to biocompatibility issues [2, 37, 60, 
79]. Their inability to chronically interface with the neurons in the brain is an imminent obstacle 
to their use in clinical applications, such as treatment of full or partial paralysis, which requires 
these implants to maintain a stable performance for the lifetime of the recipient.   
Implanted electrodes record brain activity by detecting extracellular field potentials of 
neurons in reference to a ground. The closer the electrode is to a neuron, the better the signal 
strength and the quality of the recordings. To obtain reliable signals, the distance from 
microelectrode to neuron should be within 50-100 µm range [54, 59, 80].   
Immunohistological examinations have shown a significantly lowered neuronal density 
around the implant at different time points [37, 58, 59]. Several possible causes have been 
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suggested. First, current implants are anchored to the skull on one end, and remain floating in the 
brain tissue on the end where the recording sites are located. Migration and micromotion of the 
implant occur, which may increase the distance between the electrodes and the neighboring 
neurons, as well as cause chronic inflammation [55]. Second, current implant material is not 
attractive to neuronal attachment and growth [29]; therefore neuronal processes may tend to 
migrate away from the implant. Furthermore, neuronal death or degeneration may occur simply 
through insertion of the probe or through factors that are released during chronic inflammatory 
responses [37, 51].   
Chronic gliosis results in glial sheath formation, which encapsulates the probe and 
isolates it from the surrounding brain tissue (Figure 3). Gliosis is believed to be mediated by 
macrophages, activated microglia, and reactive astrocytes. The reactive astrocytes are 
characterized by enhanced migration, proliferation, hypertrophy, upregulation of GFAP, and 
increased matrix production. The glial sheath, including a mesh of astrocytic processes, is 
formed after 2 weeks (Figure 3A), becoming compact and dense over a period of 6 weeks [2, 29, 
37, 49, 55, 58-60, 79, 81] (Figure 3B). Gliosis is hypothesized to cause significant impairment of 
implant functionality by increasing the electrode impedance, decreasing local neuron density, 
and reducing axonal regeneration around the implant [37, 49, 54, 59]. 
Several studies have addressed different methods of improving the performance of the 
chronic neuron-implant interface by modifying these implants using novel biomaterial and 
cellular designs. Some approaches use surface immobilized cues to improve the attachment and 
growth of neurons, including electrochemical deposition of conducting polymers and neuron 
promoting biomolecules on the electrodes [67, 82, 83], covalent immobilization of bioactive 
laminin-derived peptides on dextran-coated [84] and amino silane-modified silicon substrates 
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[85], electrostatic layer-by-layer deposition of laminin [86], microcontact printing of poly-L-
lysine [87], and electrospinning of silk-like polymer containing the laminin fragment IKVAV 
[88]. Soluble cues such as nerve growth factor and dexamethasone have also been incorporated 
for controlled-release to promote neuronal ingrowth or reduce glial inflammation [71, 74, 89], in 
addition to studies using drug reducing agents to decrease this inflammation [31].  Others have 
proposed modification techniques using adult neural stem/progenitor cells on the surface of the 
probe for better integration of implant and tissue [76-78].  
Many of the research efforts described above immobilize laminin or sequences of laminin 
onto the surface of neural probes for improved biocompatibility [82-86, 88]. Laminin is an 
extracellular matrix protein (ECM) and basement membrane component that has been shown to 
promote attachment of various cell types including neurons, astroglia, and fibroblasts [88, 90-
92]. This fact highlights the shortcoming of using non-neuron specific laminin on the surface of 
neural probes where an enhanced glial response is undesirable [37, 60]. The ideal surface 
modification for a neural probe would promote only neuronal attachment and neurite ingrowth, 
while minimizing glial attachment and proliferation. L1 is a neural cell adhesion molecule, 
which is expressed in developing and differentiated neurons of the central nervous system (CNS) 
and Schwann cells of the peripheral nervous system (PNS) [93-95]. L1 mediates neuron-neuron 
adhesion via homophilic binding and has been shown to promote neurite outgrowth and neuronal 
attachment in vitro [96-99]. Unlike ECM proteins, L1 comes from the immunoglobulin family 
and is known to show tightly regulated patterns of expression during development of the nervous 
system, as well as selectivity in cellular binding partners [95, 100]. When surface-bound, human 
recombinant L1 supports significantly higher levels of neuron attachment and neurite outgrowth 
relative to the ECM protein fibronectin and poly-D-lysine, while inhibiting the attachment of 
18 
 
astrocytes, meningeal cells, and fibroblasts [99]. For these reasons, L1 was chosen as a candidate 
molecule to modify the silicon surface of neural probes to specifically promote neuronal 
attachment and inhibit glial cells. The long-term objective of this research is the improvement of 
neuron-electrode compatibility in vivo for further enhancement of long-term recording 
capabilities. 
In this work, L1 is purified from murine brain tissue.  To compare the efficacy of L1 and 
laminin as substrates for neuronal or astrocytic cell attachment and growth, these proteins were 
covalently immobilized on silicon dioxide wafers along with polyethylene glycol (PEG). Surface 
analysis, including water contact angle measurements, dual polarization interferometry (DPI) 
[101], and immunochemistry, were performed to characterize the modified silicon surfaces. 
Quantitative assessment of neuron and astrocyte attachment, and neurite outgrowth on the 
different silicon surfaces was performed with primary cultures and by using 
immunohistochemistry and fluorescent imaging techniques.  
2.3 MATERIALS AND METHODS 
2.3.1 Surface modification and characterization 
2.3.1.1 Isolation and purification of the L1 protein 
The cell adhesion molecule L1 was purified by immunoaffinity chromatography as 
described by Lagenaur et al.[96]. The L1 protein was affinity purified from detergent-containing 
extracts of crude membrane fractions of murine brains using 5H7 coupled monoclonal antibody 
packed columns. The membranes were solubilized in 1% 3((3Cholamidopropyl)dimethyl-
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ammonio)-propanesulfonic acid (CHAPS) (Anatrace), centrifuged at 40,000 g for 30 min, and 
the supernatant was applied two times down the column. The antigen was eluted with 0.1 M 
diethylamine (Sigma-Aldrich) at pH 11.5 and immediately neutralized with 1M 
Tris(hydroxymethyl)-aminomethane hydrochloride (Sigma-Aldrich) at pH 6. The diethylamine 
and Tris still present in the collected L1 solution was removed by dialyzing against phosphate 
buffer saline (PBS) (Sigma-Aldrich) one day prior to use. All of the above procedures were 
performed at 4°C.   
L1 protein concentration was measured by the FluoroProfile (Sigma-Aldrich) 
epicocconone–based reagent kit [102]. The fluorescence was measured by a fluorimeter 
(SpectraMax M5, Molecular Devices) using different concentrations of bovine serum albumin 
(BSA) (Sigma-Aldrich) as standard. 
2.3.1.2 Covalent biomolecule immobilization 
Silicon wafers (p type <100> oriented) coated with 2500 Å wet thermal oxide 
(International Wafer Services Inc., CA) were used to mimic the non-conductive silicon dioxide 
surface of the probes. Wafers, 7.62 cm in diameter, were cut into approximately 1x1 cm samples 
with a diamond pen.  The heterobifunctional crosslinker method described by Bhatia et al. [103], 
was modified to covalently immobilize proteins on the silicon substrates. The silicon samples 
were cleaned and hydroxylated with HNO3 (8.0 Normal) (Sigma-Aldrich) for 30 minutes, 
followed by immersion for 5 minutes each in alcohol and chloroform (Sigma-Aldrich). The 
cleaned samples were immersed in a 2% solution of (3-mercaptopropyl) trimethoxysilane (MTS) 
in dry toluene (Sigma-Aldrich) for 2 hours in a glove bag under N2 inert gas. The thiolated 
samples were then rinsed in dry toluene, followed by immersion in absolute alcohol, and 
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treatment for 1 hour with 4-maleimidobutyric acid N-hydroxysuccinimide ester (GMBS) (Sigma-
Aldrich) dissolved in a minimum amount of N,N-dimethylformamide (DMF) (Fisher Scientific) 
and diluted in absolute alcohol to a final concentration of 2 mM. The samples were then washed 
three times and immersed in absolute alcohol for 15 min in preparation for transfer to a sterile 
hood. Three different concentrations of L1 (25µg/ml, 50µg/ml, or 100 µg/ml) or 40 µg/ml 
laminin (Sigma-Aldrich) were applied for 1 hour at 4oC on the GMBS surfaces where the protein 
solutions formed a circular droplet. The biomolecule-immobilized samples were rinsed with 
PBS, and treated with 100 µM mPEG-NH2 (Nektar) solution for 30 min to cap any active NHS 
ester groups of the GMBS still present on the surface. The control PEG samples were treated 
with only 100 µM mPEG-NH2 solution for 30 minutes right after the crosslinker step. A 
schematic representation of the immobilization is given in Figure 4. 
 
 
Figure 4. Schematic representation of the biomolecule immobilization process. L1 or laminin were 
covalently immobilized on MTS treated silicon substrates, using the hetereobifunctional crosslinker GMBS. mPEG-
NH2 was used to cap the unreacted GMBS groups. 
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2.3.1.3 Surface characterization 
To verify the steps of surface chemical reactions, wettability of the surfaces after each 
step of treatment was characterized by water contact angle measurements. The measurements 
were performed with a VCA-Optima contact angle system (AST Products Inc.). Approximately 
0.5 µL deionized water (18.2 MΩ•cm) drops were placed on the surfaces using a micro-syringe. 
Contact angle values were calculated from the captured image files using the software provided 
(VCA Optima XE) by the manufacturer. Three measurements per condition were analyzed and 
were taken promptly after completion of each modification step followed by drying under N2.  
The thickness, mass, and density of the multilayer structure present after each step of 
biomolecule immobilization were performed using the dual polarization interferometry (DPI) 
analytical biophysical technique. This technology allows for measuring of structural changes in 
real time and at subatomic resolution of reacting biomolecule layers at the solid-liquid interface 
[101]. AnaLight® Bio200 interferometer (Farfield Scientific Inc, USA) was used during 
experiments. The instrument measures two polarization responses traversing through a 
multilayer waveguide chip. Changes in the resulting optical interference pattern, caused by 
perturbation and interaction of immobilized species within the evanescent field created above the 
waveguide surface, are measured over time. Movement of the interference fringe pattern or 
phase shifts are converted into thickness and refractive index directly using Maxwell’s equations. 
Immobilized density (surface layer concentration) and mass (amount of immobilized 
biomolecule) can also be derived from these values. L1 or laminin was coated onto the surface of 
channels of a MTS waveguide chip treated with the GMBS crosslinker. PBS (pH 7.4) served as 
running buffer at 30 µl/min. L1 and laminin were each loaded and injected in the same buffer 
and mPEG-NH2 was loaded during the last step to keep the procedure consistent throughout all 
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experiments. Data was collected and analyzed using AnaLight® DAQ and Explorer proprietary 
software. 
In addition, immunostaining against L1 was performed to qualitatively verify the 
successful immobilization of this biomolecule. The L1 protein was immobilized on the 
crosslinker modified samples in a known circular area. The L1 immobilized samples were 
incubated for 45 minutes in 10% goat serum (GS) (Sigma-Aldrich) in PBS and stained with 5H7 
L1 monoclonal primary antibody at 4°C overnight, followed by 2 µg/ml Alexa 488 (Invitrogen) 
secondary antibody in 10% GS for 1 hour. Digital images of the stained samples were taken 
using a fluorescence microscope.  
2.3.2 Bioactivity and stability of immobilized L1 
The bioactivity of different concentrations of immobilized L1 (25, 50, and 100 µg/ml) was 
quantitatively verified by primary mouse neuronal cell cultures (details in the next section). 
Nitrocellulose coated glass samples with different adsorbed L1 concentrations were used as 
positive controls. Bioactivity was indicated by neuronal growth, attachment, and visible neurite 
outgrowth one day after mouse cerebellum cell cultures.                      
The stability of 100 µg/ml L1 was evaluated by incubation of the modified samples in 
DMEM media without added growth factors, for 0, 3, and 7 days at 37°C in 5% CO2. The L1 
present on the surface at the different time points was quantified by measuring the gray level 
intensity of the L1 immunostained images. 
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2.3.3 In vitro experiments 
2.3.3.1 Primary neuron and astrocyte cell cultures 
E18 Sprague Dawley rat cortices were purchased from BrainBits, LLC. Neuronal cell 
culture was performed following the methods by Brewer et al. [104]. The rat cortices were 
triturated with a 1 ml pipette and removed from Hibernate Media™ (Brain Bits, IL) by 
centrifugation at 800 x g for 1 minute. The cells were re-suspended in Neurobasal (Fisher)/B27 
(Gibco)/0.5 mM glutamine/25 μM glutamate (Sigma-Aldrich) culture medium. Cell counts were 
performed using trypan blue and cells was plated at a density of 1.5×105 cells/cm2. These rat 
cortical neurons were grown in culture for three days at 37°C in 5% CO2. During preliminary 
bioactivity verification experiments, fresh mouse cerebellum neuronal cell cultures were cultured 
at a cell density of 1.5×105 cells/cm2 in serum based media containing 10% horse serum (HS) 
(Hyclone) and Dulbecco’s Modified Eagle’s Medium (DMEM) (Gibco). These mouse 
cerebellum neurons were grown for one day at 37°C in 5% CO2. Astrocyte enriched cultures 
were prepared by tryptic digestion of a rat cortex or mouse cerebellum. The resulting suspension 
was plated on uncoated tissue culture plates and grown in DMEM with 10% fetal calf serum 
(FCS) (Hyclone). These glial cells were passaged once a week, up to 4 weeks. For experiments, 
glia were treated with 0.25% trypsin (Sigma-Aldrich), and plated at 1.5×105 cells/cm2 in 10% 
FCS/DMEM. Astrocytes were grown in culture for two days at 37°C in 5% CO2.       
Surface modified silicon samples were placed in 24 well cell culture plates (Corning 
Costar). 20 μL drops of high density cell suspensions were plated on the silicon samples and 
incubated for one hour. The corresponding media for neuron or astrocyte culture was flooded 
into the chamber following this period. Ten samples per condition were used during these 
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experiments and the protocol was repeated three times to observe reproducibility. Nitrocellulose 
coated glass coverslips with adsorbed L1 served as positive controls for cell growth throughout 
in vitro experiments.  
2.3.4 Immunocytochemistry 
Prior to immunochemical labeling the cells were fixed in 4% paraformaldehyde for 10 min. 
Monoclonal antibodies against neuronal class III β-tubulin (Covance) and the astrocyte-specific 
marker glial fibrillary acidic protein (GFAP) (Dako) were used. The samples with attached cells 
were incubated for 45 minutes in 4% GS and PBS to block nonspecific binding. Then the 
samples were incubated for 1 hour at room temperature in anti-β-tubulin III (2 µg/ml) in 4% GS 
or anti-GFAP (0.4 µg/ml) in 4% GS. Following three washes in PBS, the samples were 
incubated for 1 hour in Alexa 488 goat anti-mouse secondary (2 µg/ml) in 4% GS. Cells were 
counterstained using the nuclear dye Hoechst 33258 (Sigma-Aldrich) (2 µg/ml) in PBS. 
2.3.5 Data collection and analyses 
Digital images of the stained cells were taken using a fluorescence microscope. Cell counts and 
neurite measurements on the β-tubulin III and GFAP stained images were obtained using the 
software MetaMorph™ (Molecular Devices, PA). Neuron attachment was determined by 
counting the number of neurons that showed co-localization of β-tubulin III and Hoescht nuclear 
stain and had at least one neurite longer than cell body dimensions. Astrocyte attachment was 
determined for cells that showed co-localization of GFAP and Hoescht nuclear stain. Cell 
25 
 
attachment was analyzed for 10 (20x magnification) viewing fields per sample for a minimum of 
10 random samples per experimental condition.                                                                                                              
Neurite outgrowth was measured as the total path length of the longest neurite that 
extended from each cell body. Neurite length data is presented as an average length per cell 
number in 10 (20x magnification) viewing fields per condition. 
2.3.6 Statistical analyses 
Statistical analysis were performed using the analytical software SPSS® (SPSS Inc., IL). For 
experiments that involved the comparison of two conditions the standard Student's t-test 
(α=0.05) was performed. For comparisons involving multiple conditions, ANOVA followed by 
Bonferroni's post-hoc analysis was used (α=0.05). 
2.4 RESULTS 
2.4.1 L1 Protein Purification and Surface Characterization 
The L1 protein was purified from young murine brains. The concentrations of the L1 protein 
solutions were quantified after each purification using the FluoroProfile protein assay. The 
concentration of L1 was found to be approximately 100 ± 15 µg/ml per batch.  
Silane chemistry and the hetereobifunctional crosslinker GMBS were combined to 
immobilize L1 and laminin on the silicon dioxide surfaces. Water contact angle measurements 
for each reaction step and the summary of the data are shown in Table 1. After cleaning with 
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HNO3, the silicon surface exhibited a low initial contact angle of 27.3±1.4o. HNO3 treatment 
created a clean hydrophilic silicon surface upon each subsequent functionalization of the other 
biomolecules could be carried out. After 2 hrs in MTS the silicon surface exhibited a 
significantly higher contact angle (66.2±1.3o) than cleaned silicon (p<0.05). The significant 
increase of hydrophobicity of the MTS layer indicates the successful attachment of this molecule 
(Table 1). The subsequent surface after immersion for 1 hr in the GMBS crosslinking solution 
displayed a decreased contact angle of 58.5± 1.6o. The decrease of hydrophobicity after GMBS 
treatment indicated the successful covalent binding of the crosslinker to the MTS linked surface. 
Both protein-PEG treatments increased the GMBS surface’s hydrophobicity, with laminin-PEG 
and L1-PEG surface contact angles being 75.1±1.8o and 69.8±1.7o, respectively. This is expected 
since these proteins are relatively hydrophobic as indicated by the significantly higher contact 
angles for the adsorbed samples (85.0±1.6 o and 70.1±1.5 o, respectively). PEG-NH2 adsorbed on 
clean silicon exhibited a low contact angle (24.7±1.5o) differing significantly from mPEG-NH2 
immobilized on the GMBS treated surface, 59.1±1.3o. This difference may indicate an 
insufficient coverage of this molecule on the surface, in which case exposed GMBS surface, is 
affecting the readings. 
 
Table 1. Water contact angle measurement for covalent immobilization of different molecules to silicon 
surface (o). Data are expressed as mean±S.E.M.. Abbreviations (I-Immobilized, A-Adsorbed) (n=18). 
 
 
The surface immobilization of L1-PEG, laminin-PEG, and PEG were characterized using 
dual polarization interferometry. DPI provides direct information on thickness and refractive 
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index of the surface layers. The thickness of the immobilized layer, measured in Angstroms, 
provides an absolute quantification of surface bound molecules along one axis. Density and mass 
values, when considered together with thickness, can give an accurate indication of the 
orientation of biomolecules at the solid-liquid interface. When compared to known crystal 
structures, this can provide important information pertaining to the accessibility of active sites 
within the protein structure or even the degree to which the protein structure deforms and 
denatures on the solid substrate. Step by step characterization of the binding events are shown in 
Table 2. The immobilized L1, laminin, and PEG biomolecules had a mass amount of 2.67, 2.97, 
and 0.24 ng/mm2, respectively. The surface density of the L1-PEG, laminin-PEG, and PEG 
layers was found to be 0.54, 0.28 and 0.64 g/cm3, respectively (Table 2).     
 
Table 2. Quantitative DPI data on real-time changes in dimension (resolution <0.1Å) and density 
(resolution <0.1 picogram/mm2).  Immobilized L1, laminin, and PEG layers are expressed in terms of thickness and 
refractive index. Density and mass of the layers can be calculated from the refractive index. 
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Specific antibody staining for the L1 protein confirmed the presence of immobilized L1 
on the GMBS modified surface. 5 µl of L1 was applied forming a bubble onto the surface 
(Figure 5A). The intensity was higher at the edge of the L1 drop due to surface tension effects. 
 
 
Figure 5. Surface analysis of L1-PEG samples. (A) Alexa 488 antibody staining of L1 protein immobilized 
on a circular surface area. (B) Mouse neuronal cell growth on the area where L1-PEG is immobilized after one day 
in culture. Scale bar 50 µm.  
 
2.4.2 L1 Bioactivity and Stability 
Mouse cerebellar cells were plated on surfaces treated with different concentrations of L1 and 
the β tubulin III positive cells were counted after 1 day of growth (Figure 5B). The neuron 
attachment increased with the increase of L1 concentration used for immobilization, indicating 
that L1’s bioactivity is dose-dependent. Specifically, at the lower L1 concentration of 25 µg/ml 
neuron attachment was 108±17 cells/cm2, and at 100 µg/ml of L1 neuron attachment was 404±36 
cells/cm2 (mean±s.e.m.). Qualitatively, we observe that the surfaces treated with higher 
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concentration of L1 show longer neurite extension. This concentration effect can also be 
observed in figure 5B, in which neurites are the longest around the edge of the L1 drop where L1 
is most concentrated.              
The L1 concentration (100 µg/ml) that promoted adequate neuron attachment and neurite 
outgrowth was chosen to be used for the rest of the in vitro experiments for quantitative analysis.                                                                                                                                  
The stability of the L1 coating was evaluated by incubation of L1 immobilized samples in 
DMEM media at different time points.  The gray level intensity of the immunostained L1 spot 
after 3 days did not show any significant change respective to day 0. However, after 7 days the 
intensity of the L1 stained spot significantly decreased by 25% respective to day 0. 
2.4.3 In vitro cell culture tests 
2.4.3.1 Neuronal attachment and neurite outgrowth 
As mentioned before, L1 is a cell adhesion molecule that promotes neurite extension and 
neuronal survival, while laminin is a multifunctional ECM protein that associates with several 
cell types. Here, we investigated the effects on neuronal growth and neurite extension on 
different surface modifications using primary rat cortical neurons cultured in a defined media 
containing Neurobasal, B27, glutamine, and glutamate. Primary neuron attachment and neurite 
outgrowth data are shown in Figure 6.  
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Figure 6. Neuron attachment reported as average neurons/cm2 ± s.e.m.(A) and average neurite outgrowth 
reported as average neurite length ± s.e.m. (B) of primary rat cortical cells on silicon surfaces with immobilized 
laminin-PEG, L1-PEG, and PEG (*p<0.05). 
 
Neuron attachment was seen only on the surfaces with immobilized laminin-PEG, L1-
PEG, and PEG. The clean silicon surface, MTS, and GMBS immobilized surfaces, used as 
controls, did not support neuron attachment. The density of neurons was significantly lower on 
the PEG surfaces (p<0.01). There was no significant difference on neuronal density between the 
L1 and laminin immobilized surfaces (Figure 6A). However, neurite outgrowth, shown in figure 
6B, demonstrated that the average length of neurites on L1-PEG immobilized surfaces was 
significantly higher than on laminin-PEG immobilized surfaces (p<0.05). The length of neurites 
on PEG surfaces was not quantified due to the very sparse neuron attachment. Representative 
fluorescent images of these data are shown in figure 7. 
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Figure 7. Representative images of primary rat cortical neurons plated on silicon surfaces with 
immobilized (A) laminin-PEG and (B) L1-PEG, after 3 days in culture. Cells were stained for β-tubulin III (green) 
and the nuclear stain DAPI (blue). Scale bar 100 µm. 
2.4.3.2       Astrocyte attachment 
Astrocytic cells play a major role in the brain/tissue response to implants. Therefore, it is 
imperative to characterize the attachment and growth on candidate surfaces. The attachment of 
primary astrocytes to silicon surfaces immobilized with either laminin-PEG, L1-PEG, PEG or no 
modification are compared in figure 8A. Unmodified silicon surfaces showed attachment and 
growth of astrocytes. A significant two-fold increase in the number of attached astrocytes was 
observed on the laminin-PEG immobilized surfaces compared to control. Statistical analysis 
showed no difference between PEG surfaces and unmodified control. On the other hand, the 
number of astrocytes on the surface with L1-PEG immobilized was significantly lower than any 
other surfaces (p<0.05). 
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Figure 8. (A) Astrocyte attachment on silicon surfaces with immobilized L1-PEG, laminin-PEG, PEG, and 
unmodified SiO2 surface reported as average astrocytes/cm2 ± s.e.m. (*p<0.05 against all conditions, and op<0.05 
against laminin-PEG). (B) Representative image of primary rat cortical astrocytes plated on silicon surfaces with 
immobilized laminin-PEG after 2 days in culture. Cells were stained for GFAP (green) and the nuclear stain DAPI 
(blue). Scale bar 100 µm. 
2.5 DISCUSSION 
Silicon neural probes that can record single-unit activity from the cortex of animals or human 
patients for research purposes or clinical applications have been under development for the past 
30 years [2, 60]. The most challenging problem is how to maintain a healthy neuron-electrode 
interface for long-term applications. The goal of our study is to address biocompatibility issues 
between the probe and the brain tissue, which are thought to contribute to the chronic failure of 
these devices.                                             
In order to record single-unit activity in the brain, recording electrodes must be in 
intimate contact with the signaling neurons of the host. Previous work has made significant 
progress improving the electrical and biocompatible properties of the recording electrodes on 
silicon based neural probes [66, 67, 74, 82, 83]. However, the recording electrodes account for 
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only a small percentage of the total surface area of this device, which is made of silicon. The 
underlying motivation for the research described here is that the silicon surface will be the most 
important factor in mediating the macroscopic biological responses due to its relatively large 
area.                                           
An ideal surface modification for a neural probe will maintain the density of neurons in 
close proximity while at the same time retarding reactive gliosis. Previous research has shown 
that L1 promotes survival and growth of neurons and neurite extension [93, 96, 97]. 
Furthermore, evidence has demonstrated that L1 enhances neuronal differentiation of neural 
precursors and inhibits astrocytic differentiation via heterophilic interactions [98]. The feasibility 
of using these properties to the advantage of silicon probes is investigated here through cell 
culture studies where silicon wafers are used as a substrate in place of traditional cell culture 
substrates like tissue-culture polystyrene, glass, or nitrocellulose. A common approach to 
improving biocompatibility is deposition of laminin on the surface of silicon probes [86]. In this 
study laminin is used as the standard to which L1 functionality is compared. The first 
requirement for recording is neurons in close proximity to the probe, and laminin is an excellent 
substrate for neural adhesion. Our results indicate that L1 is just as effective at promoting neuron 
attachment to silicon surfaces as is laminin. Furthermore, it was observed that neurons which do 
in fact attach to the L1 surfaces extend significantly longer neurites compared to neurons 
attached to laminin. The implications of this for the long-term stability of recordings is still 
unclear, although from this observation we hypothesize that the neurons are “healthier” and more 
likely to remain in intimate contact with the probe over a long period of time.                     
The method of depositing a biomolecule on a surface can have significant implications to 
its specific functionality, as well as towards how the host and the probe interact in general. A 
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myriad of approaches exist for deposition of molecules that range from simple absorption to 
patterned micro-contact printing. Silicon dioxide surfaces can be conveniently functionalized to 
allow covalent attachment of molecules on the surface.  Biomolecules are attached to the silicon 
substrate through two “linking” molecules. The first linking molecule (MTS) utilizes silane 
chemistry to form an S-O-S connection to the silicon surface. It then presents a sulfhydryl group 
for the second layer to interact with. The second linking molecule (GMBS) is termed a 
heterobifunctional crosslinker because of its activated N-hydroxysuccinimide (NHS) esters and 
maleimide functional groups, and their ability to react with amine and sulfhydryl groups, 
respectively. Using the GMBS heterobifunctional crosslinker offers an advantage over 
homobifunctional crosslinkers such as glutaraldehyde, which may self-cross link and result in 
poorly defined layer structures and poor reproducibility (seen in our preliminary trials).       
Based on the DPI data, the surfaces modified using the above chemistry present a well-defined 
monolayer of protein. L1 appears to be a globular-like structure when covalently immobilized on 
the GMBS treated surface. This can be observed by the thickness data (6.37 nm) and the density 
data (0.53 g/cm3) suggesting that when this protein is on the surface it is closely packed. In 
addition, when PEG is added on the L1 surface, the mass and density doesn’t significantly 
change, suggesting that the L1 protein is tightly packed and almost fully reacted with all NHS 
ester groups. In contrast, laminin portrays an elongated structure based on its high thickness 
(12.66nm) and its low density (0.27 g/cm3). The significant change in mass between laminin and 
laminin-PEG layer suggests that there is space between immobilized laminin, which allow for 
reaction of PEG with the free NHS ester groups. The observed laminin spacings are probably due 
to steric hindrance effects between the chains of this protein. When PEG is immobilized on the 
GMBS surface alone the thickness and mass changes are low, suggesting that this molecule due 
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to its long chain is folding on the surface and forming a thin and packed layer. The folding of the 
PEG molecule on the surface might not allow for functional immobilization of this molecule.  
This improper immobilization is also suggested by the hydrophobicity of this surface implying 
the exposure of the underlying surface.                   
In vitro models can be a gross oversimplification of the in vivo situation.   The goal of 
this study was simply to explore the potential for L1 to mediate close contact with neurons. For 
this reason, it was decided that the neuron culture should be performed in a serum-free media. 
While the absence of serum proteins makes this model even more remote from the in vivo 
situation, it does allow for better isolation of the functionality of the surface. In undefined media, 
serum proteins will adsorb to the surface and mediate cell attachment. The goal was to prepare a 
surface, which mediated promotion of neuron attachment, and the model was appropriate. 
Conversely, the goal of the astrocyte studies was to examine whether the surface could limit their 
attachment and growth. For this purpose, a serum based culture model was more appropriate 
since the defined Neurobasal media does not favor the growth of astrocytes and would cloud the 
effects due to the surface alone. It has been shown previously that L1 surface selectively 
promoted neuronal growth in the mixed culture of neurons, astrocytes and fibroblasts [99]. The 
crucial portion of our results is that even in the presence of serum proteins; astrocytes do not 
attach and grow well on L1 surface. It is interesting to hypothesize about the mechanism behind 
this.                                                                                                              
Astrocytes attached on cleaned silicon surfaces without any pretreatment in serum 
containing media. They presumably do so by binding to the cell adhesive serum proteins 
adsorbed on the artificial surface. The PEG treated surfaces are supposed to minimize protein 
adsorption thereby minimizing cell attachment [105]. However, as pointed out before, our 
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covalently bound PEG surface is mildly hydrophobic which mitigates the ability of PEG to 
prevent protein fouling and further cell attachment. In the case of the laminin-PEG surface, 
higher concentration of binding sites on laminin than the adsorbed serum protein lead to higher 
astrocyte binding and growth. The surface characterization suggests that most of the GMBS 
binding sites were occupied by L1 and little PEG is actually present. In this case then the 
decreased astrocyte attachment should be a result of the surface bound L1. The direct effect 
could come from L1’s bioactivity.  As mentioned, L1 has been found to inhibit the astrocytic 
differentiation of neural precursors and proliferation of astrocytes [98]. The exact mechanism has 
not been discovered, but we speculate that the same signaling pathway might have inhibited the 
attachment and growth of astrocytes in our experiment. Since astrocytes need to bind to the cell-
adhesive serum proteins to attach to the artificial surface, the reduced astrocyte counts could also 
originate from the reduction of non-specific serum protein adsorption of the L1 bound surface. 
Pre-adsorbed albumin surface is well known to be anti-fouling [106]. The immobilized L1 may 
present a surface chemistry similar to albumin that leads to less protein adsorption. Future 
protein adsorption studies may shed more light on this issue.    
A further consideration is the implementation of these methods to long term recording 
situations.  The stability tests show that the L1 coating is not stable over 7 days at 37°C in media.  
This suggests that the immobilized L1 itself would not be responsible for the long term survival 
and interaction of neurons with the recording probe. We hypothesize however that the stability of 
this coating is sufficient for the initial attachment of neurons and neurite outgrowth. In other 
words, it seems as though the L1 coating is sufficient to provide the neurons a “foothold” in the 
critical region where recording is possible. Combined with L1’s observed effect on astrocyte 
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attachment, this possibly could alter the initial conditions of the implant milieu enough that the 
long term dynamics are also altered.                                                                                                                                           
These results are promising for the objective of this study. They suggest that if L1 is 
immobilized on the probe’s silicon surface, it can support neurons and promote neurite extension 
toward the surface of the probe. In addition, since astrocyte growth is not promoted, the 
astrocytic reaction around the implanted probe may be reduced. 
2.6 CONCLUSIONS 
L1 protein can be successfully immobilized on the silicon surface in a fashion, which retains its 
functionality. In a defined culture system, L1 enabled high-density neuronal attachment and 
promoted significantly longer neurite outgrowth compared to surfaces with immobilized laminin. 
Furthermore, while the laminin surface promoted the growth of astrocytes, the L1 surface greatly 
reduced astrocyte attachment compared to both laminin and control samples. In conjunction with 
previous work focused on promoting improved electrical properties and enhanced neuron 
attachment at the electrode sites, this work opens a path to a comprehensive surface modification 
approach for existing technologies to enable a stable, long-term neural interface for neuroscience 
research and clinical applications. 
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3.0  L1 SURFACE MODIFICATION OF SILICON BASED NEURAL PROBES 
MAINTAINS NEURONAL DENSITY AND MITIGATES GLIOSIS AT THE 
IMPLANT/TISSUE INTERFACE 
3.1 ABSTRACT 
Chronically implanted neural electrode arrays have the potential to assist patients suffering from 
various neurological traumas or neurological disorders. While these electrodes perform well in 
acute recordings, they often fail to function reliably during clinically relevant chronic settings, 
due to loss of neurons and gliosis encapsulation. Surface modification of these implants may 
provide a means to improve their biocompatibility and integration within the host brain tissue. 
We propose a method to improve the brain-implant interface by modifying the probe’s surface 
with the neural adhesion molecule L1. L1 may introduce a biological neuron friendly 
environment to maintain healthy neuronal density around the recording electrodes, and 
consequently reduce gliosis formation. In this study, we assess the tissue response of L1 
modified vs. non modified (NM) control silicon based neural probes implanted in the rat cortex 
at acute and chronic time points. The potential impact of L1 on neuronal health and survival and 
glial cell activations are evaluated with extensive immunohistochemistry and quantitative image 
analysis.  
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The results of our study show that glial inflammation persists in the surroundings of the 
NM control probes at all tested time points in rat cortex. In addition, significant decreases of 
neuronal and axonal densities were seen in the vicinity of the NM control probe. On the other 
hand, the immediate area (100 µm) around the L1 modified probe showed no loss of neuronal 
bodies and a significantly increase of axonal density relative to the NM control probe. 
Significantly less microglia and astrocyte activations were observed in the surroundings of the 
L1 modified probe than the NM control probe. These improvements in tissue response induced 
by the L1 coating are likely to lead to improved functionality of the implanted neural electrodes 
during chronic settings.  
3.2 INTRODUCTION 
Microfabricated neural electrode arrays can be implanted in the brain to stimulate or record 
populations of neurons with single neuron resolution. These devices have advanced several fields 
of neuroscience research. One such field is the study of brain-machine interfaces, where recorded 
neuronal signals from the brain are used to control an external device such as a computer cursor 
or a robotic arm [2, 11, 25, 27, 60, 107] (Figure 9). These studies have paved the way for cortical 
neural prostheses, which could potentially benefit patients with full or partial paralysis. Proof-of-
concept devices have been tested in humans [7-10]. However, these devices have not 
demonstrated consistent and reliable recordings of neural signals for durations beyond several 
months. The unstable performance of these neural probes during long-term studies has hindered 
the translation of this technology in clinical applications. 
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Figure 9. Brain Computer Interface schematic. Neural activity recorded from the brain is transmitted to a 
processor that operates an extraction algorithm on the recorded signal. The extracted control signal is fed to a robot 
controller to move the prosthetic arm, which generates feedback to close the control loop. Figure courtesy of 
Schwartz et al. [60]. 
 
Chronic neural recordings via microfabricated neural probes deteriorate over time, 
regardless of the electrode type or the animal model employed [24, 37, 54, 60]. The lifetime of 
electrode recordings has been reported to last between a few weeks up to a few months. One 
reason for recording failure is thought to be the loss of neurons surrounding the electrode area 
over time. Immunohistological examinations have shown a significantly lowered neuronal 
density around the implant, progressing over time from as early as one-week post implantation 
[37, 54, 60]. As neural recordings require proximity between the electrode and the neuron (up to 
100 µm), loss of neurons near the implant will lead to loss of recordable signals [54].  Another 
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cause of reduced electrode performance over time is chronic gliosis, which results in a dense 
cellular sheath that encapsulates the neural probe and isolates it from the surrounding brain tissue 
[37, 54, 55, 60]. Gliosis is believed to be mediated by macrophages, activated microglia, and 
reactive astrocytes [37, 58]. At the beginning of brain injury as soon as the probe is implanted in 
the brain, microglia cells are activated and start to produce a variety of proinflammatory and 
neurotoxic factors. Microglia act in concert with macrophages that have penetrated the blood–
brain barrier to phagocytose degenerating axons and myelin at the site of injury. Astrocytes, 
which become activated within hours after injury, are the second type of brain cells in the 
inflammatory response [37, 55]. Over a chronic time point activated astrocytes wall off the 
implant and the lesion created by it. Although the activation of the glial cells and their response 
to injury may prevent further tissue damage, they are known to also inhibit neuron axonal re-
growth [108]. 
Research methods to alter the implant surface are being developed to achieve a 
chronically stable electrode-tissue interface. Some of these approaches include biomaterial 
designs that inhibit surface protein adsorption [109, 110], improve neuronal attachment and 
growth to the surface [86, 109, 111], or allow for the controlled release of anti-inflammatory 
molecules to reduce inflammatory gliosis [74, 75]. Although most of the above-mentioned 
approaches have shown promise, it is still considered a challenge to achieve long-term stable 
connections between the probe and the brain tissue at the cellular and/or biomolecular level.  
We propose a more effective method to mediate the implant-tissue mismatch and to 
improve biocompatibility by introducing a neuron adhesion molecule on the probe's surface. The 
neural cell adhesion molecule L1 is a glycoprotein of the immunoglobulin superfamily expressed 
in most neurons in the central nervous system (CNS). During CNS development, L1 is targeted to 
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the surface of developing axons and growth cones and mediates outgrowth, adhesion, 
fasciculation, and guidance of axons as well as neuronal migration and survival [93, 98, 99]. L1 
has also been suggested in CNS regeneration in adult vertebrates. After spinal cord injury in 
zebrafish, the expression of L1.1, a homolog of the mammalian L1, is increased in successfully 
regenerating descending axons but not in ascending projections that fail to regenerate [112]. 
Several studies show the effect of L1 on enhancing the recovery of rats from spinal cord injury. 
The above mentioned results were achieved when the: 1) L1 expression in neurons and glia was 
induced by viral transduction [113],  2) L1 overexpressing embryonic stem cells were 
transplanted [114], and 3) axonal growth-inhibiting environment was enriched in exogenous L1 
[115]. These findings indicate that L1 is a molecule promoting CNS regeneration or preventing 
neuronal death. 
In this study, we hypothesize that L1 immobilized on the surface of neural probes will 
maintain neuronal health around the implant and induce axonal regeneration or projections 
toward the electrodes right after implantation. By maintaining neuronal density, the 
inflammatory cell adhesion and activation after injury may be reduced. Our previous in vitro 
work has shown that the presence of L1 on the surface inhibited the glial cell attachment and 
growth. Similar mechanisms that happen in vitro might also occur in vivo and these mechanisms 
could potentially reduce the inflammatory gliosis at the probe-tissue interface. 
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3.3 METHODS 
3.3.1 Microelectrode L1 modification 
Four shank chronic silicon probes available from NeuroNexus Technologies were chosen to be 
used during this study. The design and fabrication of these probes has been previously described 
from Drake et al. [116]. Three end points after electrode implantation were investigated: 1 week, 
4 weeks, and 8 weeks. Rats were implanted with non functional electrodes with thickness of 15 
μm, length of 4mm, shank width of 60-100 μm, and tip spacing of 200 μm (Figure 10).  
 
 
Figure 10.  Dimensions of the silicon based electrodes used during in vivo studies. Inset (A) schematic of 
the tethering technique used during probe implantation.  Schematics were obtained from NeuroNexus Technologies 
(www.neuronexustech.com). 
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L1 immobilization was performed on the surface of probes using silane chemistry. This 
approach allows surface patterning and immobilization of proteins or peptides on silicon 
substrates with the help of the hetero-bifunctional cross-linking reagent, 4-maleimidobutyric acid 
N-hydroxysuccinimide ester (GMBS) [103]. Poly(ethylene glycol)-NH2 (PEG-NH2) was added 
after laminin immobilization, to block the remaining reactive GMBS groups and to inhibit non-
specific protein adsorption to the surface [109] (for more see section 2.3.1.2). 
 
 
Figure 11. Schematic representation of L1 immobilization on the silicon surface of neural probes using 
MTS and GMBS covalent functionality.  
 
The surface modification was performed using the experimental procedures similar to 
those previously reported [103, 109]. Briefly, after cleaning and hydroxylation with HNO3, the 
probes were carefully immersed in a 2% solution of (3-mercaptopropyl) trimethoxysilane (MTS) 
and treated for 1 hour with 2 mM of GMBS. L1 (100 µg/ml) was applied for 1 hour at 4oC on the 
GMBS treated probe’s surface. The L1 immobilized probes were rinsed with PBS (pH 7.4), and 
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treated with 100 µM mPEG-NH2 solution for 30 min to cap the rest of the active NHS ester 
groups of the GMBS (Figure 11). The probes were implanted immediately after this process. 
3.3.2 Surgical procedures for neural implants 
Twelve adult male Sprague-Dawley rats (250 ± 20 g) were used throughout this study; with four 
animals used per time point (1/4/8 weeks).  The animals were housed in the facilities of the 
University Of Pittsburgh Department Of Laboratory Animal Resources and given free access to 
food and water. All experimental protocols were approved by the university Institutional Animal 
Care and Use Committee. The implanting techniques were followed as previously described by 
Vetter et al. [24]. The probes were implanted in the motor area of the cerebral cortex of the 
animal. General anesthesia was achieved for 5 min with a mixture of 5% isoflurane and 1 L/min 
O2 prior to surgery and maintained throughout the surgical procedure at 1-3% isoflurane. The 
state of anesthesia was closely monitored for changes in reduction of respiratory rate, heart rate, 
and absence of the pedal reflex. The animal was placed into a stereotactic frame and its head was 
shaved over the incision area. The animal’s skin was disinfected with isopropyl alcohol and 
betadine and a sterile environment was maintained throughout the surgical procedure. 
Ophthalmic ointment was applied to the eyes to prevent drying from exposure to anesthesia. A 
midline incision was made along the scalp, the skin retracted, and the periosteum was cleared to 
expose the bregma and midline. A 2-3 mm craniotomy was hand-drilled above the motor cortex 
(coordinates from bregma: AP: -0.5, ML: ± 2.5-3.5). This provided for a more controlled 
craniotomy than the iatrogenic damage that can be exposed from electric drills. Two probes were 
implanted on each hemisphere of every rat (L1 and NM control probe) (Figure 12). Several 
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stainless steel bone screws were placed in the skull to retain the dental acrylic head-cap. The 
non-functional probes were mounted on the dental acrylic around the craniotomy the same way 
they would be mounted during surgical recording procedures (Figure 10A). After probe 
mounting, the dura layer was incised using a fine dura pick (Fine Science Tools). The bond-pad 
region of the microelectrode was grasped with Teflon-coated microforceps and the penetrating 
shanks were inserted manually through the pia mater into the motor cortex. To minimize 
bleeding and tissue reaction, surface blood vessels were avoided during insertion. The 
craniotomy was filled with a biocompatible silicone elastomer (Kwik-Sil, World Precision 
Instruments, Inc.) followed by dental acrylic. The overlying skin was sutured around the dental 
acrylic head-cap and the animal was allowed to recover under close observation in the surgical 
room. To minimize variability associated with the surgery, all implants were performed by the 
same surgeon. 
 
 
Figure 12. Representative image of probe location sites on the skull of a rat shown in black rectangles where the 
craniotomy was performed. Black circles represent location of skull screws used to anchor the probe assembly. (AP 
– Anteroposterior, ML – Mediolateral).  
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3.3.3 Brain tissue preparation for immunohistochemistry  
After 1 week, 4 weeks, or 8 weeks, each animal was anesthetized with 50 mg/ml ketamine, 5 
mg/ml xylazine, and 1 mg/ml acepromazine (Henry Schein) administered via the intraperitoneal 
(IP) cavity with a dosage of 0.1 ml/100 g body weight. The animals were transcardially perfused 
with 4°C PBS prewash followed by 4% paraformaldehyde in PBS. The brains were removed and 
postfixed overnight (4°C). Following the retrieval of the electrodes for further histology, the rat 
brains were placed into 30% sucrose (4°C) sucrose solution until they sunk to the bottom. The 
brains were then cryoprotected with Optimal Cutting Temperature (O.C.T.) compound (Tissue-
Tek). Horizontal frozen tissue sections were cut to a final depth of ~4 mm from the surface of the 
cortex for all brains while skipping a section. Serial sections (20µm) were mounted directly to a 
SuperFrost Plus (Fisher) glass slides for better frozen tissue adhesion during immune staining. 
We utilized hematoxylin and eosin (H&E) stain to visualize general tissue morphology, while 
immunohistochemistry was used to visualize specific cellular markers. Chondroitin Sulfate 
antibody (CS56) was also used to visualize the up regulation of CSPGs in activated astrocytes 
around the implant site.  
3.3.4 Immunohistochemistry procedures 
To study the brain tissue response, sections taken from all brains were stained simultaneously for 
each antibody of interest at one time to minimize variability during data analysis. Six 
consecutive serial sections were used to stain for six different cell markers at four different 
depths in the brain. One serial section at each depth was stained using H&E and one using CS56. 
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The stains were chosen to visualize the presence of neuronal nuclei (NeuN), astrocytes (GFAP), 
activated microglia/macrophages (ED-1), mature axons (NF-200), microglia (Iba1), and 
astrocytes/fibroblasts/endothelial cells (Vimentin) (Table 3).  
 
Table 3. Primary antibodies used during this study 
 
 
Horizontal tissue sections were cut to a final depth of ~3 mm from the surface of the 
cortex for all brain. The six sections ranged from ~200 μm to ~3000 µm below the surface of the 
cortex and were spaced at four different intervals. 
Tissue sections were hydrated in buffer (PBS), blocked with 10% normal goat serum in 
PBS for 45min followed with PBS containing 0.5% Triton X-100 (Sigma). The tissue sections 
were then incubated overnight at 4°C, with the primary antibodies prepared in blocking solution 
with concentrations shown in Table 3. The next day sections were rinsed with PBS and incubated 
for 1 hour in either goat anti-rabbit IgG (H + L) Alexa 488 or goat anti-mouse IgG1 Alexa 488 
(Invitrogen) secondary antibodies diluted at a ratio of 1:200 in blocking solution. All sections 
were counterstained with Hoechst (Invitrogen) nuclear dye to observe all cell nuclei and cover-
slipped with Fluoromount-G (Southern Biotechnology Associates) to preserve fluorescence over 
time. Buffer was used in place of primary antibodies for control tissue samples.  
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The extracted probes were also stained to visualize the cells still present on them. The 
probes were stained following the above mentioned protocol using Iba1 and β-tubulin III 
antibody (specific for neurons), followed by counterstaining with Hoechst (see Section 2.3.4).  
3.3.5 Quantitative brain tissue analyses 
Confocal fluorescent and optical Differential Interference Contrast (DIC) images were acquired 
using a Nikon A1 confocal microscope with 10x or 20x objectives. Images for each specific 
antibody were taken in a single session to control for variability during image analysis. The 
exposure time was consistent within each marker and was set below saturation of the digital 
camera. During laser scanning confocal imaging each pixel was acquired with the same laser 
power and detector gain (sensitivity) setting for each antibody stained tissue. For analysis 
purposes a 10x objective was used with the electrode sites centered in the camera field. Four 
sections at different depths in the brain (approximately Depth 1 = 300µm, Depth 2 = 700μm, 
Depth 3 = 1100µm, and Depth 4 = 1500µm) below the rat cortex surface were imaged per each 
stain to observe the tissue response at different depths along the shaft of the implanted probe. 
Average pixel fluorescent intensity as a function of distance from the electrode-tissue 
interface was calculated using ImageJ (National Institute of Health), a public domain  Java- 
based image processing program developed at the NIH. A macro was written to perform the 
desired analysis with this program. Briefly, (GFAP/ED-1/Iba1/NF/Vimentin) images were cut 
where one out of four tracks interfaces fit within a window of ~1200 µm in height and ~400 µm 
in width. The DIC (bright field) image was first selected to draw a closed circular curve around 
the electrode-tissue interface location. The circular closed curve was verified with the matching 
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nuclei stained images.  The closed curve served as the template at which thereafter 20 µm 
segmented regions were calculated for their average gray scale pixel intensity (1-255 a.u.). The 
average intensity was calculated up to a distance of 520 µm from each side of the interface 
location (Figure 13). To correct for background differences, the intensity was normalized to the 
mean profile (found to be at the distance of 420 µm- 520 µm) of each image and averaged across 
the results for each time point condition and depth. This distance was chosen based on its 
consistency within each cellular stain to reach background intensity.  
 
 
Figure 13. ImageJ intensity analysis. (A) Horizontal representative image of a GFAP stained image. 20 µm 
step size oval bands are created from the implant interface location and average pixel intensity values from 1-255 
are measured for each band and shown as a function of distance. Scale bar 100 µm. (B) Coronal schematic of the 
region used for normalizing the intensity values. 
 
NeuN stained images were quantified by estimating the number of neurons as a function 
of distance from the electrode interface. ImageJ using a watershed installed macros was used 
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during this analysis. NeuN stains for neuronal cell bodies and Hoechst stains for all cell nuclei. 
Both images of NeuN and Hoechst were processed for cellular shape counts. The images were 
segmented using a marker-based watershed algorithm and counting cells at 50 µm increments 
away from the interface up to 600 µm away from each side of the probe’s interface (Figure 14). 
The results were normalized to the neuron count from 500-600 µm away from the interface and 
averaged across results from each time point condition and depth. 
 
 
Figure 14.  Neuron count analysis. (A) Representative image of double stained NeuN+ cells (green) and 
Hoechst+ (blue) nuclei.  Boxes created to expand up to 600 µm away from the interface, while the probe’s tract is 
placed in the middle of the boxes. Scale bar 100 µm. (B) Representative watershed algorithm computed from the 
green channel of the image A counting the NeuN+ cells at the 50 µm distance. (C) Raw NeuN+ cell count for image 
A as a function of distance from the interface.  
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3.3.6 Statistical analyses 
Statistical analyses were performed using the SPSS statistics software (SPSS, Inc.). For 
experiments that involved the comparison of two conditions, the standard Student's t-test 
(α=0.05) was performed. T-test analysis were used to compute p-values comparing NM and L1 
data at different distance increments such as 0-100 µm from the interface and up to 400-500 µm 
away from the implant/tissue interface. Differences were considered significant for p < 0.05. 
For comparisons involving multiple conditions, one-way standard analysis of variance 
(ANOVA) was used. NM or L1 probe data was compared this way through the 3 different time 
points and also through different depths. When a significant difference was found between 
groups Tukey’s Honest Significant Difference (HSD) post-hoc test was utilized to identify 
pairwise differences. Differences were considered significant for p < 0.05. 
3.4 RESULTS 
3.4.1 Implant/tissue immunoreactivity 
3.4.1.1 Neuron density and axonal immunoreactivity (NeuN and NF) 
Neuronal cell loss around the electrode sites is thought to be one of the reasons neural 
implants fail to reliable perform at chronic time points [37, 51, 54, 60]. L1 is known to 
specifically promote neurite outgrowth and neuronal survival in vitro [96, 109]. The impact of 
electrode implantation on the surrounding neuronal population was assessed by immunostaining 
for NeuN, a nuclear antigen found only in neuronal cells, and NF-200, which stains for mature 
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axons. The normalized cell counts of viable neurons around the implant’s interface at different 
time points are plotted in figure 15A-C as a function of distance (mean±s.e.m.). For the NM 
control probe neuronal decrease was evident within the 100-200 µm zone around the implant at 
all time points. The L1 modified probe maintained a normal density of neuronal cell bodies 
around the electrode interface, with a slight increase at the week 1 time point. Significant 
differences using t-test analysis were found between L1 and NM control NeuN+ cell counts at all 
time points from 0-200 µm away distance from the interface (Table 4).  
The distance for the neuron/electrode communication is known to be approximately 
within 50-100 µm [37, 54]. Normalized cell counts within the 100 µm zone around the probe 
along different depths of the implants for the L1 and NM conditions are plotted in figure 16D-F.  
Pair student’s t-tests were performed comparing the different depths and significant difference 
was seen between L1 and NM control at the all data besides: week 4 at depth 1 condition. For the 
NM probe a lower than background neuronal cell count was observed at all time points, with no 
statistically significant difference found between time points. For the L1 modified probe there 
was an initial slight increase in cell count at week 1, and then at later times the neuronal density 
seemed to reach the background level (normal tissue far from the implant) and remain 
unchanged. Neuronal cell count was also maintained at different depths along the L1 modified 
probe. Fluorescent image representations of the NeuN+ cells are shown in Figure 16.  
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Figure 15. Neuronal number and density adjacent to L1 modified implants are associated with a higher 
NeuN+ cell count than NM control implants. (A-C) Comparison of average NeuN+ cell counts between L1 and NM 
control probe at each different time point shown as the normalized average neuron number (n=14±2). (A – week 1, 
B – week 4, C – week 8). (D-F) Comparison of average NeuN+ cell counts at different depths in the cortex 0-100 
µm away from the interface for  different time points (D –  week 1, E – week 4, F – week 8). t-test comparisons 
between each group (NM vs L1) showed a significance difference *p < 0.05. No significant difference was seen 
between time points and depth within each group (NM or L1). 
 
NF-200 is a marker for mature axons. The average gray pixel intensity of NF stain was 
calculated and its normalized values to background intensity for each image are plotted as a 
function of distance (mean±s.e.m.) comparing the L1 modified and the NM control probes at 
three different time points (Figure 17A-C). The differences in NF intensity between two 
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conditions were compared at different distance zones around the electrode-tissue interface (Table 
4). Mature axons showed a statistically significant lower density around the NM probe than L1 
probes within the 100 µm zone around the electrode interface at all time points and within 100-
200 µm for the first week (Table 4). In the NM control implants, we observed reductions in NF 
reactivity than background extending as far away as 200 µm in some cases, but on average 
through the time points the reduction was in a zone of 100 µm around the implant site as 
previously described (Figure 17A-C).  However, on the L1 implants a mirrored significant 
increase in the axonal marker staining was seen (Figure 17A-C). At 0-100 µm away from the 
probe’s interface there was significance in all comparisons of the two conditions besides the 
week 8 depth 1,3, and 4 (Figure 17F). Decrease of axonal density was prominent for the NM 
probe at all depths, and the axonal density was above the background density for the L1 modified 
probes for all depths and all time point conditions. An increase of NF reactivity was seen for 
depth 1 at week 1 and depth 1 and 2 at week 8, while no changes were seen between all depths 
for the NM probes.   
Representative images for L1 and NM probes in the brain tissue stained for NF 200 are 
shown in Figure 18. The images were taken from the 8 week tissue samples, and NF is clearly 
more intense around the L1 probe tracts. NM probe had reduced NF density and showing a 
typical kill zone around the electrode.  
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Figure 16. Representative images of NeuN+ cells (green). Probe tracts traced with an oval for better 
visualization. (A,C,E) Neuronal density around the L1 probe at week 1, 4, and 8 respectively. (B,D,F) Neuronal 
density around the NM probe at week 1, 4, and 8 respectively. Scale bar 100 µm.  
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Figure 17. Mature axons adjacent to L1 modified implants are associated with a higher relative NF200 
immunoreactivity than NM control implants. (A-C) Comparison of average NF intensity between L1 and NM 
control probe at each different time point shown as the normalized average intensity in arbitrary units (a.u.) 
(n=14±2). (A – week 1, B – week 4, C – week 8). T-test comparison between the average intensity at 0-100 µm and 
the background intensity (420-520 µm) were made, significance was seen between these two measures (*p<0.05). 
(D-F) Comparison of average NF intensity at different depths in the cortex 0-100 µm away from the interface for 
different time points (D – week 1, E – week 4, F – week 8). 
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Figure 18. Representative images of NF 200 staining of 2 probe tracts shown per image. (A) L1 probe sites 
at week 4 time point. (B) NM control probe at week 4 time point.  Both images, NF 200 (green) and Hoescht (blue). 
Scale bar 100 µm.  
 
Table 4. P-values calculated from t-test analysis of the values from the NeuN and NF data at different 
interval distances from the probe interface. Yellow cells show significant p-values < 0.05 calculated from t-test 
analysis comparing NM and L1 data at 100 µm increments.  
 
3.4.1.2 Astroglia reaction (GFAP and Vimentin) 
GFAP is a commonly used marker to visualize astrogliosis, the known astrocytic reaction 
to induced brain injury. As expected from previous reported studies, GFAP expression was 
increased in the tissue surrounding the NM control probes. GFAP is expressed in mature 
astrocytes and vimentin is expressed in immature and reactive astrocytes, microglia, fibroblasts, 
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as well as endothelial cells. The intensity of GFAP and vimentin stained sections was quantified 
as a function of distance from insertion interface of the probes.  Figures 20A-C show the 
distribution of GFAP positive cells surrounding the insertion site for both L1 and the NM control 
probes. Figures 21A-C show the distribution of vimentin positive cells surrounding the insertion 
sites. The normalized intensity curves are plotted as mean ± s.e.m. from 0-520 µm away from the 
implant interface. Differences in intensity were observed as a function of time.  
 
Figure 19. Representative images of GFAP (A, B) and Vimentin (C, D) staining at the 8 week time point 
for L1 (A, C) and NM probe (B, D).  GFAP and Vimentin (green), Hoescht (blue). Arrows in figure A indicate the 
position of 2 probe tracks. Scale bar 100 µm.  
 
The characteristics of the GFAP expression differed with distance from the electrode at 
three different end points (1, 4, 8 weeks) (Figure 20). After 1 week, the peak of the intensity 
curve was around 75 µm away from the interface.  After 4 weeks, the peak in GFAP expression 
was closer to the interface (~25 µm). After 8 weeks, the expression levels of GFAP were next to 
the electrode (Figure 19A,B). These observations were seen for both conditions (L1 and NM 
probes). However, there was a significant lower level of GFAP expression for the L1 probe at all 
time points in the 100 µm zone around the interface (p<0.05) (Table 5). This trend is observed in 
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all depths along the electrode shaft at all time points (Figure 20D-F). The GFAP reaction for the 
first 100 µm away from the probe’s interface was seen to be somewhat similar for all depths at 
week 1 for both L1 and NM. At week 4 a decrease of GFAP staining was seen as the depths 
increase for both probes. While at week 8 this trend was only seen for the L1 probe.   
 
Figure 20. Tissue reaction adjacent to L1 modified implants is associated with a lower relative GFAP 
immunoreactivity than NM control implants. (A-C) Comparison of average GFAP intensity between L1 and NM 
control probe at each different time point shown as the normalized average intensity in arbitrary units (a.u.) 
(n=14±2). (A – week 1, B – week 4, C – week 8). (D-F) Comparison of average GFAP intensity at different depths 
in the cortex 0-100 µm away from the interface for different time points (D – week 1, E – week 4, F – week 8). 
Vimentin expression was similar to GFAP reaction for both L1 and NM control probes 
(Figure 19C,D). One week post implantation, vimentin expression for the NM control probe was 
61 
 
observed to be increased all around the interface and reaching normal intensity values at 
approximately 150 µm away from the probe’s interface. At 4 and 8 weeks the normal intensity 
values for the NM control probes were reached around 100 µm from the interface. The intensity 
of the vimentin positive stain was significantly decreased around the L1 modified probes than the 
NM control for all time points within 100 µm interface distance (Figure 21A-C). Pairwise 
comparisons indicated significant differences between L1 and control in the pattern of vimentin 
immunoreactivity at week 1 and 4 at the 0-100 µm zone (Table 5). The average relative intensity 
of vimentin reactivity is lower for the L1 coated probes than the NM control all depth (Figure 
21D-F). Depth differences seemed to vary at week 1 and 4 for both probes following the same 
trends but L1 probe showing significantly lower reactivity than the control probe. Week 8 results 
showed variability in depths for both probes.  
 
Table 5. P values calculated from t-test analysis of the values from the GFAP and Vimentin intensity data 
analysis at different interval distances from the probe interface. Yellow cells show significant p-values < 0.05 
calculated from t-test analysis comparing NM and L1 data at 100 µm increments.  
 
 
 
62 
 
 
Figure 21. Tissue reaction adjacent to L1 modified implants is associated with a lower relative Vimentin 
immunoreactivity than NM control implants. (A-C) Comparison of average Vimentin intensity between L1 and NM 
control probe at each different time point shown as the normalized average intensity in arbitrary units (a.u.) 
(n=14±2). (A – week 1, B – week 4, C – week 8). (D-F) Comparison of average Vimentin intensity at different 
depths in the cortex 0-100 µm away from the interface for different time points (D – week 1, E – week 4, F – week 
8). 
3.4.1.3 Microglia reaction (ED-1 and Iba1) 
Microglia form a front line of defense during acute immune reaction and at the chronic 
time point, four weeks and after, these cells are known to be part of the persistent glial sheath. 
ED-1 is a marker specific for reactive microglia/macrophages. Comparison of ED-1 
immunostaining revealed a significant elevation in immunoreactivity in animals with NM control 
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probes compared to L1 probes for all time points indicating a higher number of macrophages and 
activated microglia (Figure 23A-C). In both L1 and NM control implanted animals, most of 
ED-1+ cells were observed in close proximity to the electrode interface site (Figure 22A,C).  One 
week following implantation, ED-1 intensity signal was present surrounding the insertion sites 
(Figure 23A-C).  No significant change was seen between the intensity plots at each time point 
for the NM probes. The L1 modified probe showed a significant decrease of activated microglia 
when compared to the NM probe at all time points (Figure 23A-C). This significant decrease was 
also observed at each depth and time point for the distance of 0-100 µm away from the interface 
(Figure 23D-F). Pairwise comparisons in Table 6 reveal that L1 probe significantly reduced the 
microglia activation at 100 µm from the interface. Depth differences for the ED-1 marker were 
observed at week 4 for the NM probes and week 8 for the L1 probes.  
 
Figure 22. Representative images of ED-1 (A, B) and Iba1 (C, D) at the 8 week time point for L1 (A, C) 
and NM probe (B, D).  ED-1 and Iba 1 (green), Hoescht (blue). Scale bar 100 µm.  
 
Iba1 is expressed in normal microglia and upregulated in activated microglia. Iba1 
intensity plots showed similar trends to ED-1 reactivity (Figure 24). Pairwise comparisons 
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revealed no significant change between L1 and NM probe at week 1. Depth differences were 
observed for the NM probe at all weeks, and for the L1 probe at week 4 and 8. In addition, a 
decreased Iba1 reactivity was seen at week 4 when compared to week 1 and 8 for both probe 
conditions. The NM probe showed an increase at depth 4 week 4.  
 
 
Figure 23. Tissue reaction adjacent to L1 modified implants is associated with a lower relative ED-1 
immunoreactivity than NM control implants. (A-C) Comparison of average ED-1 intensity between L1 and NM 
control probe at each different time point shown as the normalized average intensity in arbitrary units (a.u.) 
(n=14±2). (A – week 1, B – week 4, C – week 8). (D-F) Comparison of average ED-1 intensity at different depths in 
the cortex 0-100 µm away from the interface for different time points (D – week 1, E – week 4, F – week 8). 
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Figure 24. Tissue reaction adjacent to L1 modified implants is associated with a lower relative Iba1 
immunoreactivity than NM control implants. (A-C) Comparison of average Iba1 intensity between L1 and NM 
control probe at each different time point shown as the normalized average intensity in arbitrary units (a.u.) 
(n=14±2). (A – week 1, B – week 4, C – week 8). (D-F) Comparison of average Iba1 intensity at different depths in 
the cortex 0-100 µm away from the interface for different time points (D – week 1, E – week 4, F – week 8). 
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Table 6. P values calculated from t-test analysis of the values from the ED-1 and Iba1 intensity data 
analysis at different interval distances from the probe interface. Yellow cells show significant p-values < 0.05 
calculated from t-test analysis comparing NM and L1 data at 100 µm increments.  
 
3.4.2 Qualitative observations 
To observe the cell attachment on the probes after implantation we were able to stain them with 
specific antibodies for neuron and microglia. It has been shown that microglia attach and stay on 
the probes even after removal and we were able to observe this on the NM probe at 8 weeks 
(Figure 25C). On the other we observed attached neurons and their processes along the L1 
modified probes after 1 and 4 weeks. Due to the probe’s material prone to breakage, several NM 
and L1 probes were damaged during probe removal from brain tissue or during the staining 
procedure. In addition, double staining for β-tubulin III and Iba1 was attempted, but due to the 
autofluoresence properties of the probe’s surface and failure of the double staining technique we 
were not able to visualize some of our results. In future experiments we plan to perfect these 
methods.  
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Figure 25. Representative images of neurons (A, B) and microglia (C) on the surface of probes after 
removal from fixed brain tissue. (A) L1 probe after 1 week, (B) L1 probe after 4 weeks (A and B same scale bar 100 
µm), and (C) NM control probe after 8 weeks. β-tubulin III – green, Iba 1 – green, Hoescht – blue. Scale bar 100 
µm. 
 
H&E histology was performed to observe the probe tracts and to observe general tissue 
morphology around the probe tracks. From all H&E samples we were able to observe the 
aggregation of cell bodies at the NM probe (Figure 26B). However, the L1 probes did not show 
such strong cell recruitment at the 8 week time point (Figure 26A). 
 
 
Figure 26. Representative images of H&E histology at the 8 week time point for L1 (A) and NM probe 
(B).  Scale bar 100 µm.  
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CS56 has been reported to be specific for the glycosaminoglycan (GAG) portion of 
native chondroitin sulfate proteoglycan (CSPG), which is up-regulated by reactive astrocytes. As 
expected the CS56 staining was seen to be highly increased on the surroundings of the NM probe 
(Figure 27B) when compared with the L1 probe’s surroundings at the 8 week time point (Figure 
27A). 
 
 
Figure 27. Representative images of CS56 staining (red) at the 8 week time point for L1 (A) and NM probe 
(B). Scale bar 100 µm.  
3.5 DISCUSSION 
Silicon- based neural prostheses are used as tools to study the nervous system and as therapeutic 
strategies to restore lost function in the nervous system because of trauma or diseases. Chronic 
implantation of these devices involves inevitable acute injury and chronic inflammation 
indicated by the loss of neurons and the persistent activation and encapsulation of microglia and 
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astrocytes [2, 29, 37, 55]. Current approaches to mitigate these responses include surface 
modification to promote neuronal attachment [117] and/or delivery of anti-inflammatory, 
neuroprotective, and neurotrophic factors directly at the implant-tissue interface [71, 75]. 
Although such strategies have been shown to successfully reduce the host response to various 
degrees, these strategies still remain to demonstrate a significant improvement of both neuronal 
density and gliosis at chronic time points.  
In this study, we investigated the effect of the neural adhesion protein L1 on neuronal 
density and gliosis surrounding implanted probes. We found that the presence of L1 on the 
surface of the probe can decrease the cellular inflammatory responses to implanted neural probes 
and significantly increase neural loss and axonal growth around these modified neural probes.  
We evaluated both acute and chronic inflammation at three different time points: 1 week, 
4 weeks, and 8 weeks, to explore the evolution of the inflammatory tissue responses associated 
with the presence of the L1 modified and NM control probes. These conditions were chosen 
based on literature suggestion of the two critical time points in gliosis formation. 1 week is 
known as the acute response and 4 weeks is known to be the start of the chronic response where 
the process of gliosis is somewhat complete and this also indicating the reported time-line of 
electrode recording failures in several studies [37]. To mimic similar recording testing scenarios, 
the surgical techniques performed during this study followed the standard implantation 
procedures used for chronic recording electrodes [24]. In addition, anchoring/tethering these 
electrode arrays provides a more controlled condition than the use of an untethered electrode 
model, which would likely underestimate the tissue reaction when compared to functional 
electrodes tethered to the skull. 
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Neurons of the adult mammalian CNS usually fail to regenerate following an injury [51, 
118]. This failure seems to involve the presence of inhibitory factors, as well as the absence of 
both neuronal survival and outgrowth factors. CNS neurons have some capacity to regenerate if 
they are provided with a permissive environment [61, 112-115, 118]. In particular, the glial 
environment following injury is likely responsible for many of the differences in neuron 
regenerative capacity. The adhesion molecule L1 is one of the few adhesion molecules known to 
be beneficial for repair processes in the adult CNS of vertebrates by promoting axonal growth 
and neuronal survival [98, 112-115, 119]. Previous studies and our in vitro study have shown that 
homophilic L1 interactions promote neural survival and neurite outgrowth on cultured neuronal 
cells [93, 96, 99, 109]. Therefore, we expected to find maintenance of neuronal count around the 
L1 probe and hopefully an increase of axonal density toward these implants. In this study, we 
demonstrate the spatial distribution of neuronal cell bodies as measured by NeuN 
immunoreactivity. A significant reduction in NeuN immunoreactivity was observed for the NM 
control probe at all time points. This reduction was restricted to a distance of 150-250 µm 
surrounding the NM control electrode, indicating that neuronal loss is a localized interfacial 
phenomenon. In this study we used 4 shank chronic Michigan electrodes, which are known to 
produce multiple penetrating injuries that would lead to pronounced neuronal loss around these 
types of electrodes [54, 57]. Winslow and Tresco also report loss in NF-160 within the first 100 
µm from the electrode [56]. McConell et al. show a progressive loss in number of neurons at 
chronic end points (increased loss at 16 weeks compared to 8 weeks) [51]. Most of these authors 
speculate that neurotoxic factors released by microglia best explain the observed neuronal loss. 
In addition, we believe that neuronal loss around the reported implants may result from a number 
of variables including differing surgical procedures, differing tethering forces, cells that are 
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mechanically severed during implantation, and the provision of a pathway for meningeal cell 
migration. During this study, the number of NeuN+ cells surrounding the L1 modified probe did 
not decrease compared to the background, but remained stable from 1 to 8 weeks following 
microelectrode implantation. A reduction of immunoreactivity of neurofilament surrounding the 
electrode has also been described adjacent to similar planar silicon microelectrode arrays (not 
modified) [29, 51, 54, 56]. However, in this study we observed a reduction only on the NM 
control probes, while the L1 probe showed a remarkable increase in mature axons adjacent to the 
electrode at all time points. Although, the NF activity lowered in intensity during week 4, it 
seemed to be more compact and closer to the electrode site (80 µm) by week 8.  
Nervous system cells during development adhere to themselves and their environment, 
extend axons, fasciculate and form synaptic networks via adhesion molecules such as L1. Thus, 
L1 and other neural adhesion molecules are critical for the proper function of the mature nervous 
system through their versatility or regulation/expression and other interactions in adhesion and 
neurogenesis [120]. Neurons are known to extend their axons on purified L1 via a homophilic 
interaction between L1 molecules. These L1 homophilic interactions may promote many critical 
events in neural development, such as cell recognition, adhesion, neurite elongation, and cell 
migration. L1 expression has been reported to be upregulated on sprouting axons, but not 
astrocytes, in the CNS following a lesion [121]. Therefore, L1 may play an important role in 
neural regeneration after the implantation induced injury, possibly by modifying the local 
environment, attracting the neuronal attachment, promoting the axonal regrowth and effectively 
inhibiting astrocyte activation at the site of injury.  
In this study, we also provide evidence of the spatial distribution of reactive astrocytosis 
surrounding the silicon microelectrode as determined by GFAP. In the uninjured brain, 
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astrocytes are responsible for maintaining the local cellular microenvironment within the brain, 
as well as controlling synaptic stability [37]. GFAP immunoreactivity for both conditions did not 
increase as a function of time over the 8 week period in rat cortex. It therefore appears unlikely 
that reactive astrocytes progressively push neurons away from the recording zone as has been 
suggested as a failure mechanism for single unit recording with other electrode systems [122]. 
The spatial distribution of GFAP immunoreactivity did, however, change over time. The peak of 
relative intensity of GFAP immunoreactivity was located closer to the implant surface as a 
function of time, indicating contraction of the reactive astrocytes. At week 1 we observed the 
relative intensity of the NM control GFAP staining to reach background intensity approximately 
450 µm away from the interface. At 4 weeks this distance decreased to ~300 µm and at 8 weeks 
~150 µm. Others have reported similar findings for NM silicon electrodes. The L1 modified 
implant showed similar trends although with a significant 78%, 83%, and 57% (week 1, 4, and 8 
respectively) decrease of the immediate (0-20 µm) intensity profile right at the probe’s interface. 
Although the mechanism for the reduction of the astrocytes through L1 bound on the surface of 
the probe is not known, we hypothesize the following: 1) The immediate cues that L1 might 
release at the first presence in the brain might attract neurites to this neuron friendly surface. This 
attraction of neurites keeps neuronal bodies to the proximity of the probe thus not allowing 
astrocytes to get closer to the implant, 2) Astrocytes are recruited upon the presence of a 
trauma/foreign body. The L1 surface presents a more biological surface that might disguise 
astrocytes in behaving less responsive to the foreign implant, and 3) L1 might release other 
unknown cues to inhibit/lessen astrocyte activation.   
Vimentin is expressed in reactive astrocytes but not mature astrocytes. Meningeal cells 
are fibroblast-like cells found in the meninges, including both the dura mater and pia mater. 
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Meningeal fibroblasts stain for vimentin but do not stain for GFAP, and are known to migrate 
down the electrode shaft from the brain surface and form the early basis for gliosis [66].  
Vimentin in our study seemed to be confined closer to the implant interface unlike the spatial 
distribution of GFAP immunoreactivity, indicating the presence of fibroblast closer to the 
implant interface due to the initial vascular injury. L1 showed a decrease of this phenomenon 
indicating that the same hypothetical mechanisms mentioned above for the astrocytes might be 
relevant here too. 
In our study, ED-1+ cells, a combination of hematogenous macrophages and activated 
microglia, were much more prevalent adjacent to all implants and this was observed at all time 
points. The presence of ED-1+ cells at the later time point indicates that local hemorrhaging 
occurs not only from the acute injury, but also at chronic time point. The initial implant vascular 
damage might increase the sustained activation of microglia next to the electrodes. It has also 
been suggested that ED-1 immune reaction is caused by or exacerbated by an increase in device 
motion due to electrode anchorage to the skull [55]. However, L1 modified implanted animals 
show a significant reduction of ED-1 immunoreactivity at the electrode-tissue interface. Iba1 
immunoreactivity shows  similar trends to both implants, with a broader spatial distribution since 
Iba1 stains for all microglia present in the brain tissue.  
Chondroitin sulfate proteoglycans are important inhibitory molecules in the glial 
encapsulation/scarring [35]. Upregulated CSPGs have differential sulfation patterns which 
differentially inhibit neurite outgrowth [123, 124]. Increased levels of CS56 staining were 
observed around all NM probes and less was seen around the L1 probes at all time points. These 
observations reinforce the results of the glia cells staining.   
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In summary, we report the cellular responses associated with the presence of the 
biomolecule L1 on the silicon surface of microelectrode arrays. Around all L1 modified probes, 
at all tested time points, we observed a decreased stratified cellular response composed of a small 
activated zone of microglia attached to and residing most proximal to the probe’s interface and a 
spatially distributed layer of GFAP reactive astrocytes surrounding the macrophages, and finally, 
in between these immune induced cells we saw a normal arrangement of neuronal bodies with a 
substantial spatial increase of mature axons around the L1 modified probe. We hypothesize that 
the covalent bound L1, performs similar mechanisms as it does during in vitro cellular 
environments. The presence of L1 on the surface of the probe makes the implant more 
biologically presentable to the brain cells and other molecules. In addition, we think that L1 once 
present on the surface of the probe, it might release cues to recruit other L1 through hemophilic 
binding. This phenomenon might continue for a long time thus keeping the properties of L1 we 
observe in this study intact.  Detailed studies at cellular and molecular level are required to shed 
light on the precise mechanisms responsible for the effect of L1 coating. In addition, extensive 
studies involving longer time points and functional probes would further test the longevity of the 
effect and whether it leads to improvement in chronic recording.  
3.6 CONCLUSIONS 
The current study demonstrates that covalent attachment of the neural adhesion protein L1 on 
silicon based electrode arrays significantly influences the brain tissue reaction, by showing 
decreased astrogliosis, decreased macrophage/microglial activation, and most importantly 
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increased immunoreactivity against neurofilament and NeuN at the device brain tissue interface. 
Thus we can say that the L1 protein shows neuroprotective and neuroregenerative properties 
while inhibiting gliosis at acute and chronic time points. We can conclude that L1 coating can be 
a promising strategy to improve the biocompatibility of all types of neural probes and their 
chronic performance in the brain if a modification system is first established.  
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4.0  CHRONIC NEURAL RECORDING AND IMPEDANCE MEASUREMENT IN 
THE RAT BARREL CORTEX TO EVALUATE THE PERFORMANCE OF L1 
COATED VS. UNMODIFIDED NEURAL PROBES 
4.1 INTRODUCTION 
Neurons, once severely damaged, do not repair or regenerate themselves, leaving permanent and 
devastating deficits for millions of people worldwide [118]. Neural implants that interface with 
the brain tissue to replace or bypass motor functions continue to be one of the most attractive 
solutions for several neurological traumas and disorders. Significant growth of neural interface 
technologies is predicted as our society faces population growth and aging problems. To date, the 
clinically and commercially available neural implant systems still have a lot of room for 
improvement. For example, cochlear implants are still bulky, mechanically rigid, and 
functionally limited for the delicate and small organ it replaces. Many other implant systems are 
still at preclinical stages facing many bioengineering challenges. One of the most difficult 
challenges that should be overcome for such implants is the so called “foreign body response”, 
which occurs irrespective of the size or type of device or transplant [29, 35, 40, 44-46, 48, 51, 
58, 59, 62, 125]. In the brain tissue, as described in other chapters, this foreign body response has 
the characteristic phenotype that includes inflammatory markers, reactive gliosis, and neuronal 
cell loss [35, 37, 54]. To date, significant effort has been focused on describing the events that 
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follow the implantation of neural devices. Particular emphases are directed at describing the 
chronological and spatial nature of the events that take place at the implant–tissue interface, and 
assessing the intensity of this response and how it affects device function [37, 47, 48, 126, 127]. 
It is clear that improvement of CNS implant technology requires a better understanding of the 
nature of the tissue that develops adjacent to implants, as well as a better understanding of how 
to modulate the properties of the tissue via surface modification measures or drug releasing 
procedures. 
 In the previous chapters we show the positive effect of the surface immobilized L1 
protein in vitro on neuronal attachment and neurite outgrowth and in vivo on the neuronal density 
and axonal increase at the electrode tissue interface at several time points. We hypothesize that 
reported chronic recordings might fail due to a local neurodegenerative state developing at the 
vicinity of the chronically implanted probes. This phenomenon might also be triggered by gliosis 
formation which has been shown to be characterized by neuronal loss and axonal pathology in 
close proximity to the electrode surface [37, 51, 54]. The decrease of neurons around the 
electrodes (<200 µm), leads to recording signal degradation and eventually signal loss. Neuronal 
communication is known to be achieved through the propagation of action potentials via 
membrane depolarization. The distance between the electrode and the neuronal cell membrane 
necessary for these signals to be recorded is approximately 100 µm. We hypothesize that 
maintaining neuronal vicinity through the surface bounded L1 protein will form an initial 
connection between the neurons and the electrodes, which will subsequently stabilize recording 
signals at chronic time points. 
The most common method to assess the implant induced tissue response is to insert 
model probes into the animal brains and sacrifice them at various time points. Brain tissue is 
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sectioned and stained to identify cell numbers, cell types, and other byproducts using H&E or 
immunohistochemical staining. The disadvantages of these methods are 1) the inability to follow 
the tissue reaction time course in a living animal model, 2) the large amount of time and labor 
required for histological work, and 3) the quantitative measures of tissue response which vary 
with different research groups.  
Recently, impedance spectroscopy has been proposed to be an effective method of 
assessing the electrode-tissue interface non-invasively and in real time. Impedance measure is a 
method to study the biophysics of the passive electrical properties of biological tissues. The 
complex permittivity of biological tissue is known to vary as a function of frequency. The 
frequency range to predict changes in the structure of biological tissue is 10 kHz to 10 MHz 
[128]. A common measure of assessing the performance of chronic probes in the CNS is the 
magnitude of the impedance at the 1 kHz frequency [26, 50, 129-131]. Studies have been 
performed correlating changes in tissue impedance properties and tissue response [50, 131]. In 
the days and weeks after surgical implantation of an electrode in the CNS, electrode impedance 
typically increases [60, 129, 131]. These changes have been attributed to the attachment of 
proteins and glial cells directly to the electrode and the development of the glial encapsulation 
layer around the device. After several weeks, the glial sheath becomes more compact and the 
electrode–tissue impedance typically stabilizes [131]. Thus, impedance measurements offer a 
somewhat effective assessment of tissue response over time. However, significant research needs 
to be performed to determine this relationship.    
Several researchers show extensive histology data, without correlation of recording data 
[30, 37, 54-56, 68, 71-73, 75]. Several other researches show impedance measurements, without 
correlation to recording data [50, 131]. In addition, every group has implemented their own 
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quantitative image analysis measures of histology information [30, 50-52, 54-56, 68, 75, 132].  
To date a ‘gold standard’ model to quantify the tissue response and correlate this response with 
impedance properties and a controlled recording model remains to be established. Here, we 
report our initial approach in proposing a method to correlate recording and impedance 
measurements together with tissue reaction data analysis.  
As a chronic recording model we propose the defined somatosensory cortex of the rat. 
The rat cortex shows a high degree of areal and laminar differentiation [133]. The primary 
somatosensory cortex of rodents layer IV contains periodic cell aggregates which are called 
barrels, because of their anatomical appearance [134, 135]. The arrangement of the respective 
barrels  is so that each barrel is responsible for processing the tactile information that originates 
from the corresponding contralateral whisker (Figure 28) [136]. Furthermore, each barrel in layer 
IV represents the morphological connection to a functionally related group of neurons that is 
vertically arranged across the borders of layers, also called the cortical columns [137, 138]. The 
proposed barrel cortex recording model offers a controlled mechanism to study the stability of 
signal quality over time. Implantation of modified and control probes in the barrel cortex can 
record controlled stimulated whisker response at different time points. Over time the recoded 
signal quality can degrade or remain the same as observed from the controlled whisker 
stimulation.  
We have developed our recording model with the goal of evaluating the quality, 
reliability, and longevity of neural electrodes. The model provides to evaluate several different 
parameters, allowing the researcher to measure the performance of different types of probes, or 
different modified probes, in a robust setting. In this study we report several impedance 
spectroscopy data and whisker stimulated neural recording data attained over 8 weeks. In 
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addition, we report the brain tissue histology data, acquired from two rats implanted with L1 
immobilized probes and two implanted with a non modified (NM) control probes.  
 
 
Figure 28. Schematic of the rat’s whisker-to-barrel pathway. Rat whisker follicles are indicated by colored 
circles and at each level of the pathway an isomorphic arrangement of neuronal cell groups, reflecting the layout of 
the whiskers on the snout, can be found. These are called barrelettes in the primary trigeminal nucleus of the 
brainstem, barreloids in the ventrobasal thalamic nucleus and most prominent barrels in the primary somatosensory 
(barrel) cortex. 
 
4.1.1 Probe modification and recording surgical procedure  
Four adult male Sprague-Dawley rats (250-300 grams) were implanted with one shank chronic 
multielectrode arrays purchased from NeuroNexus Technologies (Ann Arbor, MI) (Figure 29). 
Two of these electrodes were modified with L1 and the other two served as non modified 
controls. The chronic silicon probes consisted of sixteen channels with 1250 µm2 iridium 
recording sites 100 µm away from each other, lying on a planar 2 mm long single shank. The 
reported impedance (at 1 kHz) of the electrodes from the manufacturer was between 300-500 
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kΩ. All implanted materials were sterilized using ethylene oxide at least 48 hrs prior to surgeries. 
The L1 probes were covalently modified with the L1 protein applying the same silane chemistry 
protocol provided in the previous chapters (see Section 2.3.1.2). Sterile techniques were 
practiced throughout all surgical procedures.  
Rats were anesthetized for 5 minutes with a mixture of 5% isoflurane and 1 L/min 
oxygen prior to surgery. Animals were mounted on a stereotaxic frame using ear-bars positioned 
properly in the auditory meatus to firmly support their head during the surgery and anesthesia 
was maintained to effect (1-3% isoflurane and 1 L/min O2).  Surgical procedures followed as the 
ones reported in the previous chapter with little modifications (see Section 3.3.2). Briefly, each 
animal was positioned on the steriotaxic frame and its head was shaved followed by alcohol and 
betadine sterile rubs. A midline incision was made along the scalp and the skin was cut around 
the sides of the animal’s head. The periosteum was cleared to expose bregma, lambda, and 
midline.  
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Figure 29. Dimensions of the silicon based electrodes used during recording in vivo studies. Inset (A): 
Components of the recording electrodes. Images were obtained from NeuroNexus Technologies 
(www.neuronexustech.com). 
 
The coordinates for the somatosensory “barrel” cortex are 4-6 mm lateral to the midline 
and 1-3 mm posterior to bregma. A 3 x 3 mm craniotomy was centered over the barrel cortex 
using fine (0.5 mm, 45° angled tip) roungers (Fine Science Tools). In order to minimize 
iatrogenic damage, a hand drill was used to create skull screw holes and to initiate the 
craniotomy before using the fine roungers. The skull bone was very carefully removed with the 
aid of a surgical scope (Nikon). The dura was gently removed using a fine dura pick (Fine 
Science Tool). After the probe’s connector was secured to the animal’s skull, the probe was 
manually inserted into the barrel cortex using fine Teflon coated forceps (Figure 30). Stainless 
steel skull screws were inserted (dimensions = 0-80 x (1/16); Small Parts) throughout the skull. 
The electrode connector was grounded to a bone screw using its stainless steel ground wire 
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(Figure 30a).  One skull screw (0 mm lateral and 2 mm posterior to the Lambda) was left 
exposed and served as the counter electrode during impedance measurements (Figure 29b). One 
electrode was implanted per rat. After probe implantation, the craniotomy was covered with gel 
foam (Henry Schein) in 0.9% saline. The craniotomies were further sealed and protected using a 
silicon elastomer (Kwik-cast, World Precision Instruments, Inc.) to allow for floating of the 
electrode with the brain. Dental acrylic (Dental Mfg. Co.) anchored to the skull by the rest of the 
bone screws and covered the rest of the exposed skull. The animal’s skin was sutured around the 
dental acrylic and antibacterial ointment was used to protect form infection. Following 
impedance and recording measurements the animal was allowed to recover under careful 
observation in the surgical room.  All implants were performed by the same surgeon to minimize 
variability in data analysis. All procedures were approved by the University of Pittsburgh’s 
Institutional Animal Care and Use Committee. 
 
Figure 30. Image of implant in the barrel cortex of the rat brain (right). (a) skull screw used to ground the 
electrode (b) skull screw used as a counter during impedance measurements. Defined axis: ML (Mediolateral), AP 
(Anteroposterior – or Rostrocaudal [RC]). 
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4.1.2 Impedance spectroscopy and modeling 
Electrochemical Impedance Spectroscopy (EIS) is an electrochemical technique measured by 
applying an AC potential to an electrochemical cell and measuring the current through the cell. 
In vivo impedance spectroscopy can be used for electrode characterization as well as tissue 
reaction detection [50, 131, 139]. 
Impedance spectroscopy for each animal was performed right after implantation and 
every 3-4 days thereafter for the remainder of the eight weeks. Throughout the data collection 
sessions, the animals were maintained under a controlled anesthetic state (1-3% isoflurane and 1 
L/min O2). Complex impedance spectra were carried out for all animals on the same days as the 
neural recordings using the Gamry FAS2 Femtostat (Gamry Instruments). A sinusoidal voltage 
(10 mV) signal was applied to the microelectrode, and impedance magnitude and phase were 
measured referenced to a distant low impedance stainless steel skull screw.  Frequencies ranged 
logarithmically from 10 Hz to 100 kHz at a sweep of 10 points and were sampled at 100 Hz 
increments. Constant voltage, as opposed to constant current, was used such that changes in 
electrode properties due to the changing electrode potential are not misinterpreted [131].  
Prior to implantation, complex impedance spectra were measured using a 3-electrode 
method using a platinum plate as the reference electrode and a camel electrode as the counter 
electrode. Measurements were made by immersing the electrode recording sites in 0.1 M 
phosphate buffer saline (PBS). This was performed in order to test the electrical properties of the 
electrodes with our system before implantation. 
To model the impedance data, a window of 3 points above and below the 1 kHz 
frequency was taken to perform a local linear regression. It is expected that higher frequencies 
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have lower real impedance magnitudes, therefore a point was considered invalid if had a value 
deviated from the expected inverse relationship between frequency and impedance. If more than 
3 points in this window were invalid the channel was removed from the experimental data and 
considered as an outlier. Otherwise, a linear relationship was fitted with a least squares 
regression, and the 1kHz/10Hz impedance magnitude point was computed from this line. The 
magnitude impedances were averaged across all channels and the data is presented as ave±s.e.m. 
as a function of days.  
4.1.3 Neural recording experiments and analyses 
Neural electrophysiological recordings were collected from the four animals (two NM controls 
and 2 L1 modified probes) one week following surgery, and every 3-4 days thereafter over an 8 
week time course. Animals were placed in a Faraday cage under a controlled anesthetic state (1-
3% isoflurane and 1 L/min O2), and segments of high speed data were acquired using a TDT 
multi-channel acquisition system (RX5; Tucker-Davis Technologies). The contralateral whiskers 
stimulations were performed using modified air jets connected to an air compressor tank that 
supplied 20 psi of constant air pressure through solenoid valves (Humphrey Mini-Mizer). These 
valves were attached to a precision regulator (Control Air Inc.) (Figure 31). The jets were 
controlled by the solenoid valve which was actuated through the computer using a relay circuit. 
This allowed precision timing of the air stimulus, as well as pre-programmed stimulation 
patterns. During trials air stimulations were programmed to release air pressure perpendicular to 
the whiskers every second for 10 trials. A spontaneous recording (no air) was also collected for 
comparison reasons. Stimulated and spontaneous neural electrophysiological data for all 16 
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recording channels were amplified and bandpass filtered; single- and multi-unit recordings were 
sampled at 25 kHz and bandpass filtered from 300 to 3000 Hz, while local field potentials 
(LFPs) were sampled at 1 kHz and bandpass filtered from 1 to 100 Hz. Neural recording 
segments were analyzed offline and followed by further analysis using MatLab (Mathworks Inc., 
MA) and/or Microsoft Office software. 
The exact count (and therefore the exact firing rate) was somewhat arbitrary, but this 
provided a rough baseline firing rate that can then be used to determine the degree of a response 
to a stimulus. Snips were sorted using a template algorithm as a guide and then manually 
inspected for accuracy and irregular spies. No irregular spies were discarded, but an “unsorted” 
category was maintained to consider their effect. When multiple groups could be identified, these 
were manually isolated. Each category was then analyzed for consistency within the waveform 
as well as response to the stimulus. Data were reported as percent signal response. 
 
 
Figure 31. Schematic of the whisker stimulation setup and the recording setup. Air jets were positioned 
perpendicular to whiskers and contralateral to the recording implant. Raw data from all 16 channels were recorded 
from different whisker stimulation trials. 
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Peri-stimulus time histograms (PSTHs) were calculated for 10 presentations of air stimuli 
using a bin width of 1 s before and after the stimulation. These histograms were used to measure 
the neuronal response that is traditionally defined as a stimulus-locked change in the peak 
response magnitude, or firing rate, and which can be detected by summation of spike trains over 
repeated stimulus presentations. The base-line firing rate was computed by taking the mean 
across the histogram, and a channel was considered to be responding if the maximum firing rate 
on the histogram occurred following the stimulation and was at least twice as high as the mean 
firing rate. Candidate action potentials or multi unit recordings were discriminated from 
background noise based on the probability distribution of the samples given a time segment. We 
defined the noise as 2 times the root mean square (RMS) of the high pass filtered signal [32]. 
The signal reported was computed as the peak-to-peak amplitude of the sorted waveform. 
Candidate spikes were collected using a user-defined threshold, and then sorted with a 
combination of a template algorithm and manual inspection. The sorted waveforms were then 
averaged together to compute a mean waveform and the peak-to-peak amplitude of this 
waveform was defined as the reported signal.  The waveforms used for the LFP calculations 
were collected during the single pressure stimulus trial in addition to spontaneous trials. LFP 
amplitude was calculated as the difference between the 95% quantile and the 5% quantile during 
the pressure stimulus trial. This provides a good estimate of the P-to-P amplitude of continuous 
data (Equation 1). All these parameters were plotted against time, which will demonstrate the 
quality, stability and longevity of the recording.  
 
𝑆𝑆𝑆𝑆𝑆𝑆 =  𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠  𝑠𝑠𝑎𝑎𝑎𝑎𝑠𝑠𝑠𝑠𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎  2 × 𝑐𝑐𝑠𝑠𝑠𝑠𝑐𝑐 𝑎𝑎𝑠𝑠𝑠𝑠𝑎𝑎𝑎𝑎𝑎𝑎  𝑆𝑆𝑅𝑅𝑆𝑆  𝑠𝑠𝑛𝑛𝑠𝑠𝑠𝑠𝑎𝑎  𝑣𝑣𝑛𝑛𝑠𝑠𝑎𝑎𝑠𝑠𝑠𝑠𝑎𝑎  𝑓𝑓𝑛𝑛𝑓𝑓  𝑠𝑠  𝑓𝑓𝑎𝑎𝑐𝑐𝑛𝑛𝑓𝑓𝑎𝑎𝑠𝑠𝑠𝑠𝑠𝑠  𝑠𝑠𝑠𝑠𝑎𝑎𝑎𝑎   (1) 
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Standard techniques for identifying fundamental frequencies of LFP signals typically 
entail applying a fast Fourier transform (FFT) to the LFP time-series and then examining either 
the power spectrum or the spectrogram. To analyze the relation between LFP spectral power and 
spiking activity, we divided each recording session into 500 ms epochs before and after stimulus. 
This epoch length was chosen to provide a reasonable balance between temporal resolutions. To 
eliminate the effect of non-biological noise on our analysis, a threshold was defined as the mean 
plus 2 times the standard deviation of the recording activity. We calculated the mean power of 
selected data (10 stimuli per channel, over 16 channels), contained in the frequency band of 10 to 
20 Hz using FFT. Furthermore, the LFP signal energy was calculated for the data 500 ms before 
the stimulus (B.S) and after stimulus (A.S.) and averaged across channels. The percent change of 
the signal energy was calculated using Equation 2.  
 % 𝑐𝑐ℎ𝑠𝑠𝑠𝑠𝑠𝑠𝑎𝑎 =  𝐿𝐿𝐿𝐿𝐿𝐿  𝐴𝐴.𝑆𝑆− 𝐿𝐿𝐿𝐿𝐿𝐿 𝐵𝐵.𝑆𝑆
𝐿𝐿𝐿𝐿𝐿𝐿  𝐵𝐵.𝑆𝑆   (2) 
4.1.4 Tissue analysis:  Brain tissue preparation for immunohistochemistry 
After 8 weeks, each animal was anesthetized with 50 mg/ml ketamine, 5 mg/ml xylazine, and 1 
mg/ml acepromazine administered via the intraperitoneal cavity with a dosage of 0.1 ml/100 g 
body weight. The animals were transcardially perfused with 4°C PBS prewash followed by 4% 
paraformaldehyde in PBS. The brains were removed and postfixed overnight (4°C). Following 
the retrieval of the electrodes, the rat brains were placed into 30% sucrose solution (4°C) until 
they sunk to the bottom. The brains were then cryoprotected with OCT compound. Horizontal to 
the barrel cortex, frozen tissue sections were cut to a final depth of ~2 mm from the surface. 
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Serial sections (20µm) were mounted directly to a SuperFrost Plus glass slides for better frozen 
tissue adhesion during immune staining. We utilized H&E staining to visualize general tissue 
morphology, while immunohistochemistry was used to visualize specific cellular markers.  
4.1.5 Tissue analysis: Immunohistochemistry and quantitative analyses 
To study the brain tissue response, three sections between approximately 500-600 µm, 1100-
1200 μm, and 1700-1800 µm below the brain surface were chosen to be stained. The tissue 
sections were stained simultaneously for each antibody of interest at to minimize variability 
during data analysis. Six consecutive serial sections were used to stain for six different cell 
markers at four different depths in the brain (see Section 3.3.4). One serial section at each depth 
was stained using H&E. The stains used were chosen to visualize the presence of neuronal nuclei 
(NeuN), astrocytes (GFAP), activated microglia/macrophages (ED-1), mature axons (NF-200), 
microglia (Iba1), and macrophages (Vimentin). Briefly, tissue sections were hydrated in buffer, 
and blocked with serum in PBS for 45 min followed with PBS containing 0.5% Triton X-100. 
The sections were then incubated overnight at 4°C, with the primary antibodies prepared in 
blocking solution with concentrations shown in table 3 of Chapter 3. The next day sections were 
rinsed with PBS and incubated for 1 hour in either goat anti-rabbit IgG (H + L) Alexa 488 or 
goat anti-mouse IgG1 Alexa 488 (Invitrogen) secondary antibodies diluted at a ratio of 1:200 in 
blocking solution. All sections were counterstained with Hoechst nuclear dye to observe all cell 
nuclei and cover-slipped with Fluoromount-G to preserve fluorescence over time. Buffer was 
used in place of primary antibodies for control tissue samples.   
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Confocal fluorescent and optical DIC images were acquired using a Nikon A1 confocal 
microscope with 10x or 20x objectives as described in the previous chapter (see Section 3.3.5).  
For analysis purposes a 10x objective was used, while the electrode site was centered in the 
camera field. For quantification purposes the images were analyzed for average pixel fluorescent 
intensity as a function of distance from the electrode-tissue interface was calculated using 
ImageJ as described in the previous chapter. NeuN stained images were quantified by estimating 
the number of neurons as a function of distance from the electrode interface, and reported as a 
function of distance from the electrode site. 
4.2 RESULTS AND DISCUSSION 
4.2.1 Impedance spectroscopy 
We report the impedance magnitude of the electrode recording sites for the L1 and NM control 
probes at 1 kHz (the fundamental frequency of the neuronal action potential) and 10 Hz (in the 
frequency range of LFPs) in Figure 31. Impedance spectra were recorded prior to probe 
implantation (data not shown), the day of implantation (day 0), and every other 3-4 days for the 
remainder of the experiment. Data shown include 2 L1 modified probes and one NM control. 
The other control probe was omitted from the data analysis due to high impedance values that 
also correlated with low signal to noise ratio of neural recording, and an increased tissue 
reaction.  
Although it is difficult to make any definitive conclusions based on the small sample size, 
one observation consistent with both L1 coated and NM probes is that there was an initial 
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increase of the 1kHz impedance magnitude in the first week or so post implantation (Figure 
31A). This increase can be contributed to the acute tissue responses such as the increase of cells 
to the surface of the recording electrodes and the start of progressive glial encapsulation [31, 32]. 
During the remaining course of study, the impedance fluctuates between 200 and 700 kohms 
with no obvious trend observed. 
 
Figure 32. Impedance magnitude for L1 and NM probes at the (A) 1kHz frequency and (B) 10Hz 
frequency. For two of chronic probes, impedance recordings were terminated at day 42 because of apparatus 
(Gamry) failure. Data reported as mean ± s.e.m. 
92 
 
4.2.2 Neural recording analysis 
NeuroNexus electrodes work by taking the potential difference between the probe’s recording 
sites and a reference site located on the probe. During recordings, it is preferred to use a 
reference with an impedance of an order of magnitude less than the recording sites. This allows 
the rejection of the majority of common mode noise. Electrodes also use a grounding wire, 
which typically has an impedance of two orders of magnitude below that of the recording sites. 
Due to inconsistencies in manufacturer documentation, the reference and ground sites were 
reversed during our recording experiments. This resulted in a higher noise, and difficulty in 
isolating quality waveforms or single unit.  We have elected to use the data to demonstrate the 
analysis methods we developed. Future experiments will address this technical defect and true 
quantitative comparison between groups.  
A pilot study was conducted comparing the signal quality of L1 modified probes with 
that acquired from NM control probes. Single shank chronic NeuroNexus silicon based 
electrodes were implanted in the barrel cortex of SD rats while recording whisker stimulated 
activity over an 8 week time span. An air jet was used to provide controlled stimulation to the 
rat’s whiskers. Figure 33 shows representative PSTHs for the L1 and NM control at 2 different 
time points (on the left side of each figure) and LFP traces (on the right side). Stimulus - evoked 
LFPs and PSTHs were averaged across recording sites for each day.  
Observations from these figures can suggest that the L1 probe performed better through 
time than the NM control probe. Spike counts after stimulus went from 15 to 10 at day 27 and 
the average LFP trace remained approximately the same (Figure 33B). For the NM control 
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probe, the spike counts decreased from 6 to 2 and the LFP magnitude seemed to decrease at day 
27 (Figure 33D) showing almost no response to stimulus. 
 
 
Figure 33. Stimulus-evoked PSTHs and LFP traces. L1 modified probe (A) 12 days post implantation and 
(B) 27 days post implantation. NM control probe (C) 12 days post implantation and (D) 27 days post implantation.  
Sixteen channels recorded neural activity 1s prior and 1s past stimulus presentation. The red line represents the start 
of stimulus application (air). Spike counts are averaged over the sixteen channels. LFP trace is averaged over the 
sixteen channels of the raw LFP data and the light gray line represents the standard error of mean. 
 
The recording quality of the experimental probes may be evaluated by the parameters 
calculated in Figure 34. Percent response was calculated as fraction of the channels that recorded 
unit activity (above a set threshold) in response to a given air stimulus. This data can give insight 
on how well the implants are responding over time and a general idea on the degradation of 
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recordings. SNR and LFP amplitude can give further specific insight of the quality of the 
recorded signals at different time points. These data can be statistically compared to show 
differences between days or different experimental groups.  These recording metrics can also be 
correlated with impedance measures at corresponding frequencies to reveal the cause of the 
signal change. Due to the small sample size, correlation studies were not performed during this 
study. 
LFPs show neural signals that represent excitations from thousands of neurons that are 
near an electrode site. Another way of representing LFPs is through traditional spectrograms and 
power spectra. The data would give insights on neuronal firing rate concurrent with changes in 
the LFP power spectrum over time. Percent change in power energy over the frequency band of 
10-20 Hz can provide comparisons between the experimental probes over time (Figure 35B). 
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Figure 34. Data analysis representation of recording quality over the 8 week study period for L1 and NM 
control probes. (B-E) Data reported as mean ± s.e.m. 
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Figure 35. (A) Representative logarithmic power amplitude spectra showing the calculated fundamental 
frequency of the raw LFP signal for one channel. Bottom blue trace shows the raw LFP signal recorded over a 35 
second period. 10 air stimulations were performed during this time, represented as an increase in amplitude (-0.02 – 
0.02 mV y-axes). LFP data was passed through a Fourier analysis (Matlab software) to determine the logarithmic 
amplitude of the signal. The fundamental frequency was calculated from the peaks corresponding in the spectrum (y 
axis –Freq.) (B) Percent change of LFP power energy for L1 and NM control probes over time.  The power energy 
level was calculated at the 10-20 Hz frequency band over 500 ms epoch before and after stimulus presentation. 
4.2.3 Tissue analyses 
Quantification of tissue analysis followed at the endpoint of the recording experiments for all rats 
(Figure 37). Around the L1 modified probes, we observed a decreased stratified cellular response 
composed of a small activated zone of microglia attached to and residing most proximal to the 
probe’s interface site and a spatially distributed layer of GFAP reactive astrocytes surrounding 
the macrophages, and finally, in between these immune induced cells we saw a normal 
arrangement of neuronal bodies with a substantial spatial increase of mature axons around the L1 
modified probe. The results of the tissue response agree with our previous data reported in the 
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previous chapter for the L1 implants at the 8 week time point. In Figure 36 we show 
representative histology images from one of the NM probe. Increased gliosis response is shown 
by the reactivity of GFAP and ED-1 staining. This particular NM probe did also show an 
increase in impedance and a decrease of the signal to noise ratio. The results for this probe were 
not included in our reported analysis. 
Extensive studies involving more time points and functional probes would provide 
statistical difference and correlation to the reported data.  
 
 
Figure 36. Representative histology from the NM probe (A) GFAP staining for astrocytes shown in green 
and nuclei in blue. (B) ED-1 staining for activated microglia shown in green and nuclei in blue. (C) H&E staining. 
Scale bar 100 µm. 
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Figure 37. Tissue analysis at the 8 week time point for different markers as a function of distance from the 
electrode interface. Comparison between the L1 and NM control probes. Data is shown as mean±s.e.m.   
 
4.2.4 Statistical analyses 
To compare the above mentioned data we suggest using a linear mixed model ANOVA in order 
to assess the effect of time and condition on impedance and recording metrics. The random effect 
should be chosen to be the individual animal, and multiple electrode sites should be included as a 
repeated measure. Time and condition should be chosen as fixed factors. A linear mixed model 
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can also be used in tissue analysis to assess the effects of distance and condition on neuronal and 
non neuronal densities (although the data is averaged across multiple sections per animal and 
site-by-site analysis is not possible).  
Correlation between impedance and recording metrics over the course of the study can be 
achieved using a linear mixed model in which the values are first standardized, and one variable 
is defined as a predictor (covariate). The individual animal is included as a random effect to 
control for correlated observations within the same rat. Significance should be defined at the 0.05 
level for all tests. 
4.3 EXPERIMENTAL OPTIMIZATION 
To continue this study, several techniques should be optimized and followed during future 
proposed research. Surgical techniques require concentration and, due to anesthesia 
complications, need to be done to with minimum time but maximum precision. A microscope is 
required during these micro-surgeries. The head-cap is composed of dental acrylic and the 
percutaneous connector needs to be secured to the skull using bone screws. Previous research 
shows that the placement and the amount of bone screws are important during preliminary 
chronic surgical procedures [24, 137]. We observed that a large number of bone screws placed 
around the craniotomy held the head-cap tight for several months with no damage to the 
connector or to the implant. In addition, self-taping bone screws adhere to the bone without 
further damage. Precautions should be made during placement of the screws— just above the 
brain tissue—to avoid disturbance of blood vessels and the dura mater. During craniotomy, the 
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surgeon should use the rounger surgical tool. Roungers allow for accurate bone cutting and they 
minimize brain damage when compared to the hand-drill tool. Prior to probe implantation, the 
probe’s connector should be secured to the skull using dental acrylic. The probe should be 
implanted after the dura layer has been carefully removed using a dura pick tool. Implanting the 
probe on top of major blood vessels should be avoided. Insertion tool devices or micro-
manipulators should be used during probe implantation to prevent additional tissue 
damage.  Preferably, recording should start as soon as the first electrode site is implanted in the 
brain tissue and the probe is advanced in its final position.  Another way to improve implant 
location is to use subdural micro-EEG grids and their signals before probe implantation. EEG 
signals could provide a rough map of the barrel cortex area where the intracranial probe should 
be placed. 
Recording procedures require the use of an anesthetic that will not interfere with brain 
activity. However, due to the high frequency of recordings performed (2~3 times a week), the 
anesthetic should also not interfere with the animal’s health. During our studies we chose 
isoflurane as an appropriate anesthetic for the ease of procedure and quick animal recovery time. 
Choosing the appropriate amount of isoflurane during recording studies is important. However, 
more research should be performed to correlate recording activity with isoflurane induced 
anesthesia depth. Nembutal (Sodium pentobarbital) is a common used anesthetic that does not 
interfere with neural activity [140].  However, using this drug in chronic conditions requires for 
the animal to be carefully monitored during the recording procedure and the recovery period. 
Accidental overdose using this drug was observed during our preliminary studies. 
Impedance recordings should be performed before and after probe implantation. 
Impedance measures are important in determining the tissue response around each electrode site 
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with time. Standard settings during impedance measurements should be kept throughout chronic 
procedures. During neural recordings several stimulation (air puffs) trials in 4 directions (up-
down, back-forward) should be performed to observe whisker activity. When direction of 
stimulation is set, it should be used for all remaining recording procedures to observe signal 
quality of the same stimulation over time. 
All recording procedures should be performed carefully and data analysis should follow 
after each procedure to observe any discrepancies in the data. Channel mapping should be 
checked before each experimental procedure to avoid any data contradiction.  After each 
recording procedure histological methods should follow. Tissue reaction around the head-cap 
and other infections should be reported in order to further optimize surgical or other 
experimental techniques.  
4.4 REMARKS AND FUTURE INSIGHTS 
Studying the tissue response at acute/chronic time points of functional neural implants can offer 
critical information needed to advance the use of these implants in clinical setting. This work, 
represent our first steps towards this direction.  
To our knowledge correlation between neural probe performance and tissue response still 
remains to be determined. This can be due to the lack of a good animal model for chronic 
recording evaluation. Also, discrepancies in recording quantification techniques and tissue 
analysis among groups exist. In this chapter we report the initial steps we have taken to 
determine a model that most researchers could use to study the chronic tissue response of 
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functional neural implants. Our model, although still needs further improvement, provides the 
necessary steps towards a more comprehensive study. We describe a controlled stimulation 
paradigm that offers the stable neural signals including both spike and LFP data, both of which 
are useful signals for neural prostheses. Several parameters have been established, such as SNR, 
unit amplitude, LFP amplitude, and can be used to evaluate the recording quality, stability and 
longevity over time. Our tissue processing and image analysis protocols offer comprehensive 
information of the cellular composition of the neural electrode/tissue interface. The image 
analysis technique we apply offers inclusive information about all pixel data provided in the 
stained image. These protocols may be used to study neural probes of different material, shape, 
or size. To perform a complete and conclusive study, additional number of animals at more time 
points would be necessary. Unfortunately, this was not possible for this thesis work due to 
time/funding constrains. However, the animal model and various protocols established will 
enable us to perform a more comprehensive study in the near future.  
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5.0  FUTURE EXPERIMENTS 
As mentioned in the previous chapters, chronic failure of implantable microelectrodes is a major 
problem in preventing the recording of long-term stable neural signals. This problem has 
hindered research on these probes and also the availability and readiness for clinical use. One of 
the mechanisms of long-term failure is the host tissue response and more specifically its effect on 
decreased neuronal activity around the implant. Several investigators are studying the tissue 
response after implantation, but to our knowledge the recoding performance coupled with tissue 
response has not been evaluated to a great extent.   
The objective of this research was to develop a biocompatible and neuroadhesive coating 
that can sustain long-term connectivity of the implant with the host neurons.  The L1 molecule 
was specifically chosen with the goal to improve the implant-tissue interface and improve the 
long-term recording signal and recording stability of the electrodes. Our results show the 
promising effects of L1 when immobilized on the surface of silicon based neural probes. While 
we performed extensive histology measures, we believe that applying several other techniques 
will fortify the results of this study.  
The continuation of this work would entail studying the role of L1 at other time points. 
Longer implant time-points will be needed to investigate whether or not L1 has the same effect 
on tissue response beyond 8 weeks. Earlier time points before 1 week will be necessary to further 
elucidate the initial effect of L1.  
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Future studies should also investigate the effect of inflammation and neurons surrounding 
chronic implants using several other markers. We are looking at investigating neurodegeneration 
by staining with Fluoro-Jade C, which is a marker for dead/dying neurons [51]. From the 
literature on chronic electrode implants, little is known about expression of pro-inflammatory 
cytokines, such as IL-1, IL-6, and TNF-α at the tissue electrode interface [30]. These 
biomolecules are thought to be released from activated microglia. Future work should investigate 
cytokine expression of tissue across several early (days) and late (months) time points at the 
electrode interface. 
 We are also working on analyzing combined impedance and recording changes for 
different time point animals. Future work will entail increasing animal sample size and the 
frequency of impedance measurements and recordings. In addition, correlations that reveal 
trends between impedance measurements, recordings, and tissue response will be made when 
animals are sacrificed at each time point of the impedance measurement/recording. We are 
working on perfecting our recording protocol to adjust for all these measures.  
It will also be necessary to develop other joint methods for reducing the effects of 
inflammation, while mitigating the neurotoxic effects. Combining drug releasing electrodes with 
surface immobilization of L1 should reduce the gliosis response to a great extent. Work in our 
laboratory has been done involving coating and release of dexamethasone from polypyrolle 
doped electrodes [74].    
At last, we are also investigating the effect of L1 when coated on other type of electrodes 
varying is size and material (Appendix). This is a necessary investigation to propose the use of 
L1 as a widespread application technique.  
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APPENDIX 
L1 COATING STRATEGIES 
We have developed an L1 surface immobilization method that can coat the surface of Parylene-
C, the insulating layer of the Floating Microelectrode Array (FMA) electrodes [20].  
Parylene-C wires that are used in the assembly of the FMA electrodes were cut to be 
approximately 0.5-1cm long during in vitro experiments. Parylene-C wires were coated with L1 
and laminin (positive control) following an established protocol by our lab. Briefly, the Parylene-
C wires were plasma treated for 10 seconds and immersed in either 100 µg/ml of L1 or 40 µg/ml 
of laminin protein solutions for 1 hour and followed by a PBS rinse. All conditions, (untreated 
wires, plasma treated wires, and protein (L1/laminin) coated wires) were mounted on round glass 
coverslips using Kwick Sil and placed in 24 well cell culture plates (Costar). To observe the 
effect of the L1 protein and its bioactivity while its present on the surface of the wire, three 
primary cell types (neurons, astrocytes, and microglia) were chosen for the in vitro experiments. 
Seven samples per treatment condition were tested for each cell type (n=7). 
E18 Sprague Dawley rat cortices were purchased from BrainBits, LLC. Neuronal cell 
culture was performed following the methods by Brewer et al. The rat cortices were triturated 
with a 1 ml pipette and removed from Hibernate Media™ (Brain Bits, IL) by centrifugation at 
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800g for 1 minute. The cells were re-suspended in Neurobasal (Fisher)/B27 (Gibco)/0.5 mM 
glutamine/25 μM glutamate (Sigma-Aldrich) culture medium. Neurons were plated on top of the 
Parylene-C wires (n=7 per condition) at a density of 1.5×105 cells/cm2 and were cultured for 
three days at 37°C in 5% CO2.  
Primary astrocyte-enriched cultures were prepared by tryptic digestion of rat cortices 
from BrainBits, LLC. The resulting suspension was plated on uncoated tissue culture plates and 
grown in Dulbecco's modifed Eagle's medium (DMEM) with 10% heat-inactivated fetal bovine 
serum (FBS (Hyclone). Astrocytes were passaged once a week, for up to 4 weeks. For 
experiments, glia were treated with 0.25% trypsin (Sigma–Aldrich), and plated on the samples at 
a density of 2×105 cells/cm2 in 10% FCS/DMEM. Astrocytes were grown on the wire samples 
and maintained in culture for 2 days at 37°C in 5% CO2. 
Rat microglia-enriched cultures with a purity of >98%, were prepared from whole brains 
of 1-day-old Fischer 344 rat pups as described previously and with minor modification by Liu et 
al.[141]. In brief, the cells were seeded until they reached confluency into 175- cm2 culture flasks 
and maintained in DMEM/nutrient mixture-F12 containing 10% heat-inactivated FBS, 2 mM L-
glutamine, 1 mM sodium pyruvate, 100 mM non-essential amino acids, 50 U/ml penicillin, and 
50 mg/ml streptomycin. The culture medium was replenished one and four days after plating and 
changed every three days thereafter. Upon reaching glial confluence (14–17 days), the microglia 
were separated from astrocytes by shaking the flasks at 180 rpm for 45 minutes. The collected 
microglia cells were spun for 5 min at 1100 rpm and were seeded on the Parylene-C samples at a 
density of 1.5×105 cells/cm2 in DMEM/F12 medium for 3 days at 37°C in 5% CO2. 
Prior to immunocytochemistry all cultured cells grown on the Parylene-C wires were 
fixed in 4% paraformaldehyde for 10-15 min. The samples were then incubated for 1 hour at 
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room temperature in the appropriate antibodies against β-tubulin III (neurons), GFAP 
(astrocytes), or ED1 (activated microglia), at concentrations of 2 µg/ml in 4% goat serum. All 
cells were counterstained using the nuclear dye Hoechst 33258 (Sigma-Aldrich) (2 µg/ml) in 
PBS. Digital images of the stained cells were taken using a fluorescence microscope. Cell counts 
were performed on the top visible surface of each wire and cell number per surface area was 
calculated. The statistical analysis was performed using the standard Student’s t-test (α = 0.05) 
for comparison between two conditions. 
 
RESULTS 
 
Untreated Parylene-C samples do not support cell attachment and growth. Plasma treatment was 
found to be necessary and effective in promoting the attachment of the L1 protein onto the 
Parylene-C surface, demonstrated by the excellent neuron attachment and neurite outgrowth. In 
addition, significant reduction of astrocyte and microglia growth was observed when compared 
to untreated Parylene-C wire conditions.  
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Figure 38. Data representing cell attachment and growth per surface area on untreated and modified 
Parylene-C wires. L1 treated wires showed a significant difference when compared to the untreated wires *p<0.05. 
β-tubulin III stains for neurons, ED1 stains for activated microglia, and GFAP stains for astrocytes. 
 
The quantitative cell counts are summarized in Figure 38. Number of neurons increased 
on both types of wires with the L1 and laminin coating (Figure 39). However, there are 
significantly less astrocytes on the L1 coated wires than the laminin coated wires. This is 
expected based on the different bioactivities of the two proteins. L1 is a neuron specific adhesion 
molecule that promotes neuron growth and adhesion via homophilic binding, while laminin is an 
extracellular matrix protein that can bind to many types of cells via Integrin receptors. Therefore, 
the L1 treated surface, selectively promotes the neuron attachment and not the astrocytes and 
microglia. 
These results suggest that plasma treatment and coating of L1 protein onto the surface of 
Parylene-C can provide a more biocompatible surface in the brain with the hope of improving 
109 
 
the chronic tissue-implant interface by reducing gliosis and maintaining neuronal density around 
the implant. 
 
 
Figure 39. Representative images of β-tubulin III positive neurons grown on A) L1 modified Parylene C 
wire and B) laminin modified Parylene C wire. Scale bar 100 µm. 
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